Latest / Yaron Brook Show / Pre-requisites for Wanting FM Healthcare with Amesh Adalja & Reinier Schuur | Yaron Brook Interviews
Transcript
- 0:03Speaker 1: A lot of the fundamentals of widows and an individual loss.
- 0:14Speaker 1: This is the show, all right, everybody, welcome to you
- 0:22Speaker 1: on book show on this Monday, January twentieth, and inauguration day.
- 0:28Speaker 2: We have a new president. It is official. I'll be
- 0:32Speaker 2: in next few days.
- 0:33Speaker 1: I'll be taking a part on the executive voters and
- 0:38Speaker 1: his talk a little bit about his speech today. We'll
- 0:42Speaker 1: do that in the coming shows. But today we've got
- 0:45Speaker 1: a real treat. I think we've got. Amish adulgia Is
- 0:50Speaker 1: is back and he's being joined by Ratire. Both are
- 0:56Speaker 1: affiliated with FKAM, the Association for Free Choice in Medicine.
- 1:02Speaker 2: I got it right this time, and Ray.
- 1:06Speaker 1: Is the executive director. Amish is on the board, chairman
- 1:13Speaker 1: of the board and chairman of the board. And so
- 1:16Speaker 1: we're we're talking really we'll were talking about healthcare and
- 1:23Speaker 1: kind of the prerequisites. What is it going to require
- 1:27Speaker 1: to get Americans to buy into private healthcare.
- 1:31Speaker 2: You know, I did a show with the way I.
- 1:35Speaker 1: Would move us towards free market healthcare, and there obviously
- 1:38Speaker 1: lots of options and how you would actually go about
- 1:41Speaker 1: getting there and what it actually looks like the and
- 1:43Speaker 1: I don't think anybody knows that's the beauty of markets,
- 1:45Speaker 1: but how do we actually get Americans to even consider
- 1:49Speaker 1: such an idea? I mean, the real problem today is
- 1:53Speaker 1: it's not even on the table. So we thought we'd
- 1:56Speaker 1: dedicate today's show to that, to the kind of ideological
- 1:59Speaker 1: intellectual work that needs to be done, and to a
- 2:03Speaker 1: large extent I think AFCAM is going to be doing.
- 2:06Speaker 1: But maybe let's start away with with just a brief
- 2:12Speaker 1: description of what AFCAM is and what your role in
- 2:17Speaker 1: it is going to be sure.
- 2:19Speaker 3: Ron, and thanks for having us. Just a minor correction,
- 2:22Speaker 3: it's Americans for Free jure, here you go.
- 2:24Speaker 2: I knew I got something wrong, Okay.
- 2:26Speaker 3: But it's yeah, and it's we call it AFCAM for short. Yeah.
- 2:32Speaker 3: So AFCAM was founded in nineteen ninety three, that's thirty
- 2:36Speaker 3: two years ago. Now it's dedicated to educating Americans so
- 2:43Speaker 3: that they can advocate for individual rights and pre markets
- 2:47Speaker 3: and healthcare. And I took over as the executive director
- 2:52Speaker 3: from Richard Rawlson last year and I have a PhD
- 2:56Speaker 3: in philosophy, specialized philosophic medicine. And yeah, I remember, in
- 3:01Speaker 3: many ways of rebooting the organization, it was a bit
- 3:04Speaker 3: dormant for a few years, but there's a lot of
- 3:07Speaker 3: interest in healthcare. It's something I'm very passionate about. And
- 3:12Speaker 3: Image was already on the board before and now he's
- 3:16Speaker 3: stare person and he's also been involved with FKHAM for
- 3:20Speaker 3: many years. Image, if you wanted to share your involvement.
- 3:25Speaker 4: It was probably right around the mid nineteen nineties when
- 3:29Speaker 4: I not long after I read Atlas Shrug. I was
- 3:32Speaker 4: interested in medicine and I'd heard about this organization and this,
- 3:35Speaker 4: if you remember, in the nineteen nineties, was during the
- 3:38Speaker 4: Clinton presidency, and that's when there was a major push
- 3:42Speaker 4: for single payer healthcare or a step major step towards
- 3:46Speaker 4: it with Hillary Clinton and the Clinton Care Plan. And
- 3:50Speaker 4: AFKHAM was very active at that point, with Leonard Peacoff
- 3:53Speaker 4: doing town halls, lots of literature being published, a very
- 3:56Speaker 4: active executive director at that time, Scott Holler, and they
- 4:00Speaker 4: were meeting with congressional staff, and I was just somebody
- 4:04Speaker 4: that got a little bit involved at that time, was
- 4:05Speaker 4: very interested in and I found their policy briefs and
- 4:08Speaker 4: their plans very very interesting.
- 4:10Speaker 5: And then, as Ray said, it was kind.
- 4:12Speaker 4: Of less active, less active, although it was still active
- 4:16Speaker 4: and Richard Rawson was getting letters published in the Wall
- 4:18Speaker 4: Street Journal regularly, and we had this opportunity when Ray
- 4:24Speaker 4: finished his PhD. Was finishing his PhD was very interested
- 4:27Speaker 4: in the philosophy of medicine and free market principles. So
- 4:31Speaker 4: we had a couple of meetings and we kind of
- 4:33Speaker 4: reinvigorated and started to get it back active to sort
- 4:37Speaker 4: of its former self. And that's I think going to
- 4:40Speaker 4: be an exciting opportunity because I think af KIM is
- 4:43Speaker 4: very different as you'll hear versus all the other free
- 4:46Speaker 4: market thing tanks that have their own health care plan,
- 4:48Speaker 4: and I think hopefully will start to gain some traction
- 4:51Speaker 4: and start to outline a way forward.
- 4:55Speaker 2: That's great.
- 4:55Speaker 1: Yeah, I was literally involved during the Clinton Care and
- 5:01Speaker 1: then and then Obamacare, and and I know a lot
- 5:03Speaker 1: of the founders, so it's it's really great to see it,
- 5:08Speaker 1: to see it rebooted, and I'm excited to see what
- 5:11Speaker 1: you guys have installed us in the years we're still young,
- 5:16Speaker 1: so in the decades to come, as as we fight
- 5:19Speaker 1: for more freedom in every realm of American life, but
- 5:23Speaker 1: in particular in the realm of healthcare. So so one
- 5:28Speaker 1: of the one of the big challenges that I find
- 5:32Speaker 1: when talking about healthcare.
- 5:35Speaker 2: You know, it was just I travel a lot.
- 5:37Speaker 1: I spend a lot of time in countries that have
- 5:40Speaker 1: socialized health care, and they all feel very superior because
- 5:44Speaker 1: of that fact. And one of the things I find there,
- 5:47Speaker 1: but you also find in the United States, is this
- 5:49Speaker 1: idea that well, America still has already has free market
- 5:55Speaker 1: health care. So why do people think that and and
- 5:59Speaker 1: what do we do to change that?
- 6:04Speaker 3: Yeah, I mean that's a really important question, and it's
- 6:08Speaker 3: it's quite remarkable. I mean, you're on you were at
- 6:12Speaker 3: the Cambridge Union debating why should we privatize the NHS.
- 6:17Speaker 3: And what's interesting about that is that in many ways
- 6:20Speaker 3: there was a debate about American healthcare. People kept bringing
- 6:24Speaker 3: American health care back in here and there, And even
- 6:28Speaker 3: when I talked to my relatives, I'm from Europe and
- 6:30Speaker 3: from the Netherlands, and when I say I'm moving to America,
- 6:34Speaker 3: they say like, oh, you'll have to give up your
- 6:36Speaker 3: health care. Right, So there's this astounding amount of misunderstanding.
- 6:43Speaker 3: I'm not even sure if it's an issue of a
- 6:45Speaker 3: lack of knowledge, and we can get into that of
- 6:50Speaker 3: what even free market in healthcare would be like, and
- 6:53Speaker 3: the assumption that America has it.
- 6:57Speaker 5: I think just even some statistics.
- 6:59Speaker 4: If you think about the US, the majority of healthcare
- 7:02Speaker 4: dollars are taxpayer dollars, it's not private dollars. So we
- 7:06Speaker 4: and if you look at how much the US government
- 7:08Speaker 4: spends in terms of taxpayer funds on healthcare, it's higher
- 7:12Speaker 4: than any of the countries that have you know, quote
- 7:14Speaker 4: unquote socialized medicine. So I think that this is this
- 7:17Speaker 4: farce that we have a free market here. We have
- 7:20Speaker 4: some elements of freedom, but so does the UK, so
- 7:24Speaker 4: does Germany. And I think it's just a different mix
- 7:26Speaker 4: that we have here. And I think if people in
- 7:29Speaker 4: some of the distortions that we see are not the
- 7:31Speaker 4: result of a free market system but kind of the
- 7:34Speaker 4: worst of both worlds that we have here with this
- 7:36Speaker 4: mixed system that is inefficient and has all kinds of bureaucracy,
- 7:40Speaker 4: all kinds of force put into it. And it gets
- 7:44Speaker 4: blamed on free enterprise, but it's not a free enterprise
- 7:46Speaker 4: system and it hasn't been.
- 7:47Speaker 5: If you look.
- 7:48Speaker 4: The first time the government got involved in healthcare was
- 7:50Speaker 4: actually in the John Adams administration. That's when they started
- 7:53Speaker 4: paying started getting involved. So this is something that we've
- 7:56Speaker 4: had since the very beginning.
- 8:00Speaker 5: Country.
- 8:00Speaker 4: You've never really had a free market system.
- 8:03Speaker 2: So what do you think there is this confusion?
- 8:06Speaker 1: What is it about our system that is different than
- 8:10Speaker 1: the UK and the rest of Europe that makes them
- 8:13Speaker 1: so confused that even Americans, I think, think generally we
- 8:16Speaker 1: have a market system here.
- 8:18Speaker 4: It's because we don't have universal coverage, meaning that not
- 8:21Speaker 4: everybody has health insurance. That we've got maybe twenty or
- 8:26Speaker 4: thirty million people that don't have health insurance. So that's
- 8:29Speaker 4: the difference between many of the other countries where, for example,
- 8:31Speaker 4: in Germany, everybody has health insurance, then they have private
- 8:34Speaker 4: insurance on top of that, or the same thing in
- 8:36Speaker 4: the UK, and I think that's the thing that we
- 8:38Speaker 4: don't have. That's the who actually ranks healthcare systems based
- 8:42Speaker 4: on if there's universal coverage. So it's the universal coverage
- 8:45Speaker 4: issue is why it gets labeled as free enterprise, even
- 8:48Speaker 4: though that's really not the essential aspect of it.
- 8:51Speaker 3: And I think another important aspect is how people who
- 8:56Speaker 3: call themselves advocates for free markets and healthcare sell it
- 9:02Speaker 3: and present it. And in many cases, people who call
- 9:05Speaker 3: themselves advocates for free healthcare. What they're really advocating for is, well,
- 9:09Speaker 3: we want to apply some free market principles to this
- 9:12Speaker 3: government program or and not at all questions like why
- 9:18Speaker 3: is insurance playing the kind of role that it's playing, right,
- 9:20Speaker 3: Like is this a phenomena of the free market or
- 9:23Speaker 3: is this No one, no one questions that it's it's
- 9:25Speaker 3: a question of well, don't you like transparency, or like
- 9:29Speaker 3: don't you like competition? Let's add a little bit of
- 9:32Speaker 3: those ingredients to the system we have. There's no real
- 9:36Speaker 3: kind of thinking like what kind of system do we
- 9:38Speaker 3: even have where like no one knows prices. It's it's
- 9:43Speaker 3: definitely not like any other industry where you would go
- 9:46Speaker 3: and buy and get certain services.
- 9:50Speaker 2: But to ext it seems that this is I mean,
- 9:53Speaker 2: it's a broader problem.
- 9:54Speaker 3: Right.
- 9:54Speaker 1: People don't know what capitalism is. They don't know what
- 9:56Speaker 1: free markets are.
- 9:57Speaker 2: Period.
- 9:58Speaker 1: They think about because capitalist I mean, if you, particularly
- 10:01Speaker 1: Europeans think America's capitalist is the epitome of capitalism, I
- 10:06Speaker 1: just can't I go and say we don't have capitalism
- 10:08Speaker 1: in the world, and they.
- 10:09Speaker 2: Look at me like I'm crazy. Of course you do.
- 10:10Speaker 2: America's capitalist.
- 10:13Speaker 1: And this seems though, like one instance, but a particular
- 10:17Speaker 1: particularly bad one, where they just can't they can't conceptualize
- 10:23Speaker 1: what free market's on, and they can't conquitize it. They
- 10:25Speaker 1: can't think in terms of what that looks like.
- 10:28Speaker 3: Yeah, but I think there's something more specific here, because
- 10:32Speaker 3: I find that when I meet Americans or Europeans and
- 10:38Speaker 3: they say like, oh, ray, you're moving to America. Isn't
- 10:40Speaker 3: that like privatized healthcare? Blah blah blah. I find that
- 10:44Speaker 3: kind of going through with them like all the ways
- 10:47Speaker 3: that it's not a free market doesn't convince them. No,
- 10:51Speaker 3: in a way that's different for other industries. So I
- 10:55Speaker 3: think they think there's something different about healthcare. And so
- 10:58Speaker 3: I don't think it's an issue of them not knowing
- 11:01Speaker 3: the facts. I think it's more an issue of there
- 11:04Speaker 3: appears to be a kind of a cognitive bias towards
- 11:09Speaker 3: assuming that, well, what you want complete freedom and healthcare
- 11:14Speaker 3: really there's a kind of assumption like no, like you
- 11:17Speaker 3: need controls here. So whenever I hear someone say like, oh,
- 11:22Speaker 3: American healthcare is privatized or free market, and I bring
- 11:26Speaker 3: up all these counterexamples, what they're really saying is that well,
- 11:30Speaker 3: they're saying one of two things. They're either saying, Okay,
- 11:33Speaker 3: there's a little bit too many controls here and like
- 11:35Speaker 3: we need to loosen it up, or they think it's
- 11:39Speaker 3: not enough controls. Right, So it's just the assumption that
- 11:43Speaker 3: healthcare is different and should be different for moral reasons,
- 11:49Speaker 3: and we'll get into that as well, But so definitely,
- 11:55Speaker 3: I mean, we're talking about the kind of prerequisites that
- 11:57Speaker 3: we would need for Americans to want a free market
- 12:01Speaker 3: in healthcare. One of those pre requests is they would
- 12:03Speaker 3: actually have to know what a free market in healthcare is,
- 12:06Speaker 3: and they don't. The problem is that even if they do,
- 12:10Speaker 3: it's a question of it I would accept it, and
- 12:13Speaker 3: we can get to that next.
- 12:15Speaker 2: Yeah, you know, I think that's right.
- 12:19Speaker 1: And put aside farns who might not know and don't
- 12:22Speaker 1: really don't really get it. How well do you think
- 12:27Speaker 1: Americans understand what's going on in healthcare? I mean, they
- 12:29Speaker 1: know sometimes the ancients company doesn't cover them.
- 12:33Speaker 2: They know, they're frustrated.
- 12:36Speaker 1: But like this idea, the government spends more than fifty
- 12:38Speaker 1: percent of all the dollars spend on healthcare and things
- 12:40Speaker 1: like that, To what extent do you think that is
- 12:43Speaker 1: something that Americans are are really an extent to which
- 12:46Speaker 1: it's all regulated aware of.
- 12:49Speaker 5: I don't think that they actually have a good grasp
- 12:51Speaker 5: of that.
- 12:51Speaker 4: I think they know that there's programs like Medicare and
- 12:53Speaker 4: Medicaid and the VA and the Military Healthcare SYSM. They
- 12:57Speaker 4: know that there's those things, but I don't think they've
- 12:58Speaker 4: ever added it up or totaled it. And I think
- 13:00Speaker 4: they don't recognize how much of even you know, what
- 13:03Speaker 4: quote unquote is private medicine is still government controlled medicine
- 13:06Speaker 4: in terms of the licensure of doctors, licensures of hospitals,
- 13:09Speaker 4: the licensures a number of beds in a hospital. Uh,
- 13:12Speaker 4: the way insurance, what insurance products are offered, what insurance
- 13:15Speaker 4: has to has to cover, what insurance can charge, how
- 13:18Speaker 4: much of an insurance company's profits have to be reinvested
- 13:22Speaker 4: in the insurance planner, used on benefits rather than for
- 13:25Speaker 4: for dividends or whatever it may be. All of that,
- 13:27Speaker 4: I don't think they quite understand that it's completely You know,
- 13:30Speaker 4: you always talk your own about the finance industry being
- 13:32Speaker 4: one of the most controlled industries. I think the healthcare
- 13:35Speaker 4: industry probably a second, if not almost the same as
- 13:37Speaker 4: the finance in terms of if you add up you know,
- 13:40Speaker 4: all of the state licensing, the federal all the federal
- 13:44Speaker 4: programs Medicare and medicaid, to be all of that put together,
- 13:47Speaker 4: I think it's it's really a government managed system that
- 13:50Speaker 4: we have here that has some elements of of of
- 13:54Speaker 4: privatization and but not not very many. And and all
- 13:57Speaker 4: those private things are by permission. They're kind of and
- 14:00Speaker 4: they're very throttled.
- 14:02Speaker 2: Yeah.
- 14:02Speaker 1: I mean the very fact that everybody who works in
- 14:04Speaker 1: healthcare has to be licensed, which is which is not
- 14:09Speaker 1: necessarily true in finances, is one big difference and one
- 14:15Speaker 1: that makes the industry even more regulated.
- 14:19Speaker 3: So I mean, it's it's it's it's a case like
- 14:20Speaker 3: I says that people don't understand and to the extent
- 14:24Speaker 3: that they try to make sense of it, what I
- 14:26Speaker 3: see more often is that it's the language of the
- 14:29Speaker 3: markets that they think best explains what's wrong with it.
- 14:33Speaker 3: It's the profit motive, it's it's elements of capitalism, right,
- 14:38Speaker 3: So like if they have an understanding, it's that understanding
- 14:41Speaker 3: and which is, uh, what's the false Yeah, I mean they.
- 14:46Speaker 4: Can they'll also realize all the force creates everybody at
- 14:49Speaker 4: each other's throats, that every that doctors versus hospital administrators,
- 14:53Speaker 4: versus insurance companies versus they're all against each other because
- 14:56Speaker 4: there's so much force there and that creates all these
- 15:00Speaker 4: conflicts of interests that are irreconcilable under the current system.
- 15:03Speaker 4: And and that's all these things that you hear, all
- 15:06Speaker 4: of these horror stories about health insurance companies denying suth
- 15:08Speaker 4: that comes from it's they're all a function of this
- 15:10Speaker 4: system that's been created, that's this mongrel mix, and it
- 15:14Speaker 4: often gets blamed on the profit motive, but they don't
- 15:16Speaker 4: understand that the system already sets people up against each
- 15:19Speaker 4: other and that's that's what's causing all of the all
- 15:22Speaker 4: of these issues.
- 15:25Speaker 1: So can you can you give an example of that amission?
- 15:28Speaker 1: I mean, you know where it because it is still
- 15:31Speaker 1: a kind of a suicide game that the regulators set
- 15:33Speaker 1: it up.
- 15:34Speaker 2: Right.
- 15:34Speaker 4: Yeah, So let's think, so an insurance company denies a claim.
- 15:37Speaker 4: They deny a claim because if they paid out the claim,
- 15:40Speaker 4: maybe it will cost a lot of money and then
- 15:41Speaker 4: they're going to have to increase premiums. But they have
- 15:43Speaker 4: certain price caps on what a premium can be charged.
- 15:46Speaker 4: So so they're they're even within their business model, they've
- 15:49Speaker 4: got competing interests to say, if we decline, if we
- 15:51Speaker 4: accept all these claims and we don't really scrutinize them,
- 15:54Speaker 4: premiums are going to go up, and then we're going
- 15:56Speaker 4: to get faulted for having too high premiums. So it's
- 15:58Speaker 4: it's the whole system is rigged to fail.
- 16:01Speaker 5: Almost.
- 16:03Speaker 1: Yeah, absolutely, So, Uh do you think if people understood,
- 16:11Speaker 1: if they understood we don't have a free market, would
- 16:14Speaker 1: they would Americans want a free market?
- 16:17Speaker 2: I mean, is that the direction they would want to had?
- 16:19Speaker 1: I mean, I remember the days where the polls showed
- 16:23Speaker 1: that most Americans didn't like Obamacare, And my sense was
- 16:27Speaker 1: they didn't like Obamacare because what didn't socialize the system enough,
- 16:30Speaker 1: not because they wanted more free market healthcare. But do
- 16:34Speaker 1: you have a sense that the direction would be if
- 16:37Speaker 1: they understood the role of government would be towards more
- 16:40Speaker 1: freedom and healthcare.
- 16:42Speaker 4: I would say that the thing that they don't like
- 16:43Speaker 4: about Obamacare is it's called the Obama That's what they
- 16:46Speaker 4: don't like about it. Because they liked it when it
- 16:48Speaker 4: was Romneycare. They and they like it and that's why
- 16:52Speaker 4: there's nothing. They can't repeal and replace it because they
- 16:54Speaker 4: actually most of our policymakers actually agree with most of
- 16:57Speaker 4: the principles of Obamaca. They just don't like that it's
- 16:59Speaker 4: called Obamaca. If it was called Trump Care, I suspect
- 17:01Speaker 4: they would all support it. But I don't necessarily think
- 17:05Speaker 4: that everybody wants They don't understand what a free market is,
- 17:08Speaker 4: and I don't think that they would be prepared to
- 17:10Speaker 4: accept things. So if you said that, you know, some
- 17:12Speaker 4: billionaire could get a kidney transplant faster because he paid
- 17:15Speaker 4: the donor, they wouldn't accept that. They would find that
- 17:17Speaker 4: morally repugnant. And I use this analogy. You know, you
- 17:20Speaker 4: talk about price gouging when there's like a hurricane for water,
- 17:25Speaker 4: healthcare is like that three sixty five seven twenty four
- 17:27Speaker 4: to seven.
- 17:27Speaker 5: So if they would not they don't.
- 17:29Speaker 4: Just like they don't like someone having to pay twenty
- 17:31Speaker 4: dollars for a bottle of water during a hurricane, they're
- 17:34Speaker 4: not going to like it. If some rich person can
- 17:37Speaker 4: get a kidney transplant and pay a donor, you can't.
- 17:39Speaker 4: It's illegal to actually pay for that pay a donor
- 17:42Speaker 4: in the United States. So I think that they They
- 17:45Speaker 4: probably would find most of this morally repugnant because this,
- 17:48Speaker 4: you know, this idea of altruism or that that need
- 17:51Speaker 4: need is what matters here rather than ability to pay
- 17:54Speaker 4: or you know, a free transaction between a free a
- 17:57Speaker 4: free market transaction between two voluntary parties. That's not something
- 18:00Speaker 4: that they that's even you know, in their mind, because
- 18:03Speaker 4: they treat healthcare very differently. They treat it like an
- 18:06Speaker 4: emergency situation all the time, and they don't.
- 18:08Speaker 5: And that's where you never see.
- 18:10Speaker 4: Free market principles during an emergency situation, as we saw
- 18:13Speaker 4: during COVID.
- 18:14Speaker 3: Yeah, and I think it's it's it's worse than that.
- 18:17Speaker 3: It's it's not only that people view healthcare as like
- 18:22Speaker 3: an ongoing hurricane, because it's one thing to like blame
- 18:26Speaker 3: the water bottle company for a price gouging and like
- 18:30Speaker 3: being selfish and whatnot. But these are doctors, and the
- 18:34Speaker 3: expectation is that, well, aren't doctors supposed to like sacrifice?
- 18:39Speaker 3: And you see this in the history of medicine, is
- 18:41Speaker 3: that there's something off when people think of the mixture
- 18:47Speaker 3: of medicine and business, because business is about self interest
- 18:51Speaker 3: and medicine has its ethos of the doctor slaving away
- 18:56Speaker 3: for their patients. Now, of course doctors work very hard,
- 18:59Speaker 3: and that's part of what it means to be in medicine,
- 19:02Speaker 3: but it's fundamentally the value creation. There is a trade.
- 19:06Speaker 1: So what way did it manifest itself in in uh
- 19:10Speaker 1: in history? Were doctors more of businesses, more viewed as
- 19:14Speaker 1: businesses once?
- 19:16Speaker 3: Well, I mean the thing is that they sometimes like
- 19:20Speaker 3: to pretend that they present themselves like oh, the solo
- 19:23Speaker 3: practitioner who can hang up their shingle and like have
- 19:27Speaker 3: their black bag. And but the AMA had like a
- 19:31Speaker 3: ban on doctors making a profit off of other doctors labor, right.
- 19:37Speaker 1: So you couldn't employ them they they could make a
- 19:41Speaker 1: profit of another doctor's labor.
- 19:43Speaker 3: Yes, Like there were kind of barriers towards the corporate
- 19:46Speaker 3: practice of medicine and those kinds of things. There were
- 19:49Speaker 3: other kinds of bands, like bands on doctors, like holding
- 19:52Speaker 3: patents on on drugs, and the viewers that like, well,
- 19:56Speaker 3: that's that's too much like business, that's too commercial. And
- 20:01Speaker 3: there were like these old AMA reports from like the
- 20:04Speaker 3: nineteen tenths braving about the commercialism in medicine and that
- 20:08Speaker 3: that's evil.
- 20:10Speaker 4: So many people, you know, and both My parents are physicians,
- 20:12Speaker 4: so I've been around this for a very long time.
- 20:15Speaker 4: I think that there's this idea that doctors should be
- 20:18Speaker 4: above all of that about petty concerns about money, and
- 20:21Speaker 4: the AMA and other organizations thought of medicine as a
- 20:23Speaker 4: guild and they would protect that guilt to make sure
- 20:25Speaker 4: that you got adequate what they call not they don't
- 20:27Speaker 4: call it, you know, a salary. They say reimbursement for
- 20:29Speaker 4: your time. They use the word reimbursement because they don't
- 20:31Speaker 4: want to say profits. So doctors do get paid well,
- 20:35Speaker 4: but it was it was something that they wanted to think,
- 20:38Speaker 4: they thought of as dirty or you know, I can
- 20:40Speaker 4: remember my mom saying, was blood money that when you
- 20:43Speaker 4: saw a doctor get very wealthy. So I think that
- 20:46Speaker 4: there was this this issue that doctors were going to
- 20:50Speaker 4: get paid well somehow, somebody would take care of them,
- 20:52Speaker 4: whether that's a hospital, whether that's insurance company of the government.
- 20:55Speaker 4: But that's not something that they wanted to talk about
- 20:57Speaker 4: with patients. That's not something they wanted to be flashy about,
- 20:59Speaker 4: and flashy doctors were off often kind of derided. But
- 21:02Speaker 4: I think there was you know, obviously there were elements
- 21:05Speaker 4: of business that happened. Happened when you were a solo
- 21:07Speaker 4: practitioner that you have an office and office staff and
- 21:10Speaker 4: you have to do all of that kind of stuff,
- 21:11Speaker 4: but you never really want to. I think it was
- 21:14Speaker 4: very difficult for doctors to deal with patients that had
- 21:17Speaker 4: unpaid bills. They often would forgive it, or I can
- 21:20Speaker 4: remember my dad getting paid in food or getting paid
- 21:23Speaker 4: with candy or whatever. At one time, my mom got
- 21:25Speaker 4: paid in marijuana, which yet before it was legal, so
- 21:28Speaker 4: it was not something that they wanted to touch. And
- 21:31Speaker 4: I think that's also because that probably goes back all
- 21:34Speaker 4: the way to you know, Hippocrates, where maybe it's not
- 21:37Speaker 4: explicitly talked about with ability to pay, but I mean
- 21:39Speaker 4: there was that understanding that doctors are kind of society's
- 21:42Speaker 4: resource and not something that's kind of part of the
- 21:45Speaker 4: commercial system.
- 21:47Speaker 3: Yeah, which is not to say that there can be
- 21:49Speaker 3: a place for that in the same way that the
- 21:51Speaker 3: lawyer does things pro bono. But to actually have value creation,
- 21:55Speaker 3: you have to have people thinking about medicine as a
- 21:59Speaker 3: value that they can can create and trade, because if
- 22:02Speaker 3: you don't have that, then you have nothing to be
- 22:04Speaker 3: charitable about it. That's where the value comes.
- 22:06Speaker 1: From Do you think that has changed at all over
- 22:10Speaker 1: the years. I mean, you're seeing more and more doctors
- 22:12Speaker 1: get MBAs for example, and view their practices as businesses.
- 22:17Speaker 1: Or is that mostly because of the increased bureaucracy the
- 22:20Speaker 1: doctors have to deal with these days?
- 22:22Speaker 4: So I would say so, First of all, most doctors
- 22:25Speaker 4: don't have their own practices. Most doctors, the majority of
- 22:27Speaker 4: doctors and United States, are employed by a hospital system,
- 22:30Speaker 4: so they often get MBAs. At least my friends, my
- 22:32Speaker 4: mother got it, and my mother has an MBA too.
- 22:34Speaker 4: Was not because they were trying to run their business better.
- 22:36Speaker 4: It's because they were trying to become more hospital administrators,
- 22:39Speaker 4: to get more involved on that side of it with
- 22:41Speaker 4: the insurance companies, with hospital management. That's what they get
- 22:44Speaker 4: interested in because they increasingly get kind of tired and
- 22:47Speaker 4: burned out of the day and day out seeing patients.
- 22:48Speaker 4: That sometimes they get an MBA to rise in the
- 22:51Speaker 4: corporate hierarchy because they're often, you know, a doctor at
- 22:54Speaker 4: a big medical center will be kind of just a
- 22:57Speaker 4: worker drone.
- 22:58Speaker 5: They're not.
- 22:59Speaker 4: They don't have that kind of professional respect that they
- 23:02Speaker 4: once had. They thought of as employees, and they're fungible
- 23:04Speaker 4: they can be removed, they can replace them with another
- 23:06Speaker 4: doctor very quickly. So one way that doctor's gaining job
- 23:09Speaker 4: security and these big, big health systems is to get
- 23:12Speaker 4: an MBA, so now they become an administrator. And that's
- 23:15Speaker 4: I think the big trend towards getting MBAs within medicine,
- 23:18Speaker 4: not so much to run practice. And I would say
- 23:21Speaker 4: most doctors that are employed by healthcare systems look down
- 23:23Speaker 4: on doctors that are.
- 23:24Speaker 5: In private practice.
- 23:26Speaker 4: They look down on them if they're solo that they're
- 23:28Speaker 4: kind of not in academic medicine anymore. They're just they're
- 23:31Speaker 4: just kind of doing this and not really part of
- 23:34Speaker 4: part of, you know, the mainstream of medicine anymore. If
- 23:36Speaker 4: you you kind of thought of as selling out if
- 23:38Speaker 4: you have a solo practice, even though you might make less,
- 23:41Speaker 4: it's just that you're like taking yourself out of that
- 23:44Speaker 4: kind of the rat race that everybody's involved in now
- 23:46Speaker 4: in medicine.
- 23:47Speaker 3: Although there is a small and growing movement of people
- 23:52Speaker 3: who just want to drop out of that whole system
- 23:56Speaker 3: and they don't take insurance and they have their own
- 24:00Speaker 3: concaiers practice and other kinds of direct primary care and whatnot.
- 24:06Speaker 3: And what's interesting is that. I mean their pieces, for
- 24:09Speaker 3: example in the New York Times, like with theories on
- 24:13Speaker 3: the evil profit motive in these big systems, and then
- 24:16Speaker 3: they go to these smaller businesses and they actually present
- 24:21Speaker 3: them as like, well, these people actually care about their patients.
- 24:24Speaker 3: But they don't make the connection there with the profit motive.
- 24:27Speaker 3: They just think that, oh, they just escaped the corporate
- 24:30Speaker 3: profit motive and now they have their small business so
- 24:33Speaker 3: that's fine.
- 24:33Speaker 5: Yeah.
- 24:34Speaker 4: So there is this burgeoning direct primary care and concierge doctors,
- 24:37Speaker 4: but it's very restricted and very limited.
- 24:39Speaker 5: Not every specialty you can do it.
- 24:40Speaker 4: You have to have a specialty that's like family medicine
- 24:42Speaker 4: or primary care or something where you don't need to
- 24:45Speaker 4: be around.
- 24:45Speaker 5: Hospitals or use hospitals.
- 24:47Speaker 4: Because as soon as you start taking Medicare, which you
- 24:49Speaker 4: have to do if you're in a hospitals, that you
- 24:51Speaker 4: if you're a doctor in this based in the hospital,
- 24:53Speaker 4: you cannot be part of any of that concierge world.
- 24:56Speaker 2: So the concierge world does not take Medicare patients.
- 25:00Speaker 4: Not only does it not take them, you can't have
- 25:02Speaker 4: a concierge practice on the side and then also be
- 25:05Speaker 4: a regular hospital doctor, which is this is that's more restricted.
- 25:08Speaker 4: So in England you can you can be an NHS
- 25:10Speaker 4: doctor and then have a fancy practice on a Harley
- 25:11Speaker 4: Street and take and and they don't mind. In the
- 25:14Speaker 4: United States, if you if you, if you do not
- 25:16Speaker 4: take Medicare.
- 25:17Speaker 5: You you you can't. You can't.
- 25:19Speaker 4: You can't dabble in both systems. You can't be a
- 25:21Speaker 4: concierge and take Medicare. It's it's they make it very
- 25:23Speaker 4: very difficult. That's one policy fix that would be great,
- 25:26Speaker 4: but I think it's very difficult to do.
- 25:28Speaker 1: So I hit Medicare soon it means I have no
- 25:31Speaker 1: access to the concierge that that world.
- 25:34Speaker 5: Well, you have to pay cash.
- 25:35Speaker 4: But but your doctor also couldn't be a doctor to
- 25:38Speaker 4: a Medicare patient.
- 25:39Speaker 5: You can't.
- 25:39Speaker 4: You can't charge different prices. You can't have that. So
- 25:42Speaker 4: suppose you suppose it doesn't really matter so much if
- 25:45Speaker 4: you're you're a primary care doctor because you don't need
- 25:47Speaker 4: to be in the hospital. But for someone like me
- 25:49Speaker 4: or that that you know, you couldn't find, like a
- 25:52Speaker 4: surgeon that's a concierg surgeon other than a plastic or
- 25:54Speaker 4: a bariatric surgeon. You're not going to find a surgeon
- 25:57Speaker 4: that can do an appendectomy, take a patient from the
- 25:59Speaker 4: r and do appendectomy and then also do bury after
- 26:02Speaker 4: surgery for cash.
- 26:02Speaker 5: They won't allow that because it's not well.
- 26:05Speaker 1: Although, of course, in an ideal system, you think that
- 26:07Speaker 1: a general practitioner would want to be able to go
- 26:10Speaker 1: to the hospital, right, I'd like him to to you know,
- 26:13Speaker 1: to to be with me, wouldn't, no matter what what
- 26:16Speaker 1: is going on, So that would be ideal.
- 26:18Speaker 4: Yeah, that's that's that's a different trend of like now
- 26:21Speaker 4: we don't. Now we have what are called hospital medicine
- 26:23Speaker 4: doctors or hospitalists. They usually do all the hospital care,
- 26:26Speaker 4: and most primary care doctors don't go to the hospital anymore.
- 26:32Speaker 2: Right, So yeah, yeah, agree.
- 26:37Speaker 3: Yeah, I mean, so we've covered two things that like
- 26:42Speaker 3: one thing that you would need for Americans to want
- 26:45Speaker 3: free markets and healthcare. They would need to know what
- 26:47Speaker 3: they are. Yeah, but that's not enough because they might
- 26:49Speaker 3: know it and I might not want it, and I
- 26:52Speaker 3: need to want it, but not just because it works
- 26:55Speaker 3: or some free market think tank says like, oh well
- 26:59Speaker 3: you'll like it, you have like more affordable care. They
- 27:02Speaker 3: have to want it morally, right, So they have to
- 27:04Speaker 3: think that a free market in healthcare can be moral,
- 27:08Speaker 3: and I think they're the barrier is that people just
- 27:11Speaker 3: view healthcare as something different, right, it's it's and I
- 27:16Speaker 3: think that for that reason, there's a special challenge in
- 27:19Speaker 3: healthcare in arguing for free markets. And then the question
- 27:24Speaker 3: is what is the view that they have of healthcare?
- 27:27Speaker 3: So just that they think it it can't be subject
- 27:30Speaker 3: to a free market. And I don't mean here is
- 27:33Speaker 3: simply the argument that economists make that oh, there's a
- 27:39Speaker 3: what's it called asymmetry of information, all these technical things.
- 27:44Speaker 3: There's something deeper here about how people think that healthcare
- 27:48Speaker 3: is different.
- 27:50Speaker 2: What is that? What's what's the deeper thing?
- 27:53Speaker 3: I mean, it's it's the view that once healthcare exists,
- 27:59Speaker 3: it's like the air, right, and like what you're not
- 28:02Speaker 3: going to like charge me for air, are you? And
- 28:05Speaker 3: it's it's a view that a mission has talk on
- 28:09Speaker 3: the history of government in American healthcare is described as
- 28:12Speaker 3: the kind of garden of Eden view or man of
- 28:15Speaker 3: from heaven view. And it's you see this in all
- 28:19Speaker 3: sorts of ways that once a particular drugs becomes available
- 28:26Speaker 3: or a certain standard is created within the healthcare system
- 28:30Speaker 3: that well, you need it, and therefore it's it's it's
- 28:34Speaker 3: it's it's like the water in the air. A.
- 28:38Speaker 4: Yeah, So as a non philosopher, I think I'm going
- 28:41Speaker 4: to try and delve into philosophy a little bit.
- 28:43Speaker 5: I think that most people have accepted.
- 28:45Speaker 4: John Rawls's ideas, even whether they don't know his name
- 28:48Speaker 4: or not, that they think of a world from that,
- 28:51Speaker 4: you know, that that point, that that veil of ignorance
- 28:53Speaker 4: where they don't know if they're going to be rich,
- 28:54Speaker 4: they don't know if they're going to be healthy, and
- 28:55Speaker 4: anythink what kind of a society do I want to
- 28:57Speaker 4: live in it? And most of them will want a
- 28:58Speaker 4: society where no matter their ability to pay, no matter
- 29:02Speaker 4: how sick they are, no matter what pre existing condition
- 29:04Speaker 4: they may have, that they have the ability to get
- 29:07Speaker 4: the best healthcare that or the health care that would
- 29:10Speaker 4: would fix that problem. That's how they think of it,
- 29:12Speaker 4: just like they think, you know, they think so they
- 29:15Speaker 4: do think of it like air or water. Now that
- 29:17Speaker 4: it's not something that can be subject to market forces,
- 29:21Speaker 4: they've got to create a society where everybody gets that
- 29:24Speaker 4: healthcare irrespective of their ability to pay, and irrespective of
- 29:28Speaker 4: the condition that they might they might be in in
- 29:29Speaker 4: their choices. That's what they's that's what their ideal is.
- 29:32Speaker 4: And I think that's why they see it differently, is
- 29:34Speaker 4: because this is completely ingrained into it, this this veil
- 29:37Speaker 4: of ignorance and trying to set up a society where
- 29:39Speaker 4: the least off are no worse off. And they think
- 29:42Speaker 4: that in a free enterprise system, the worst off are
- 29:45Speaker 4: going to be worth the ones that are the most
- 29:47Speaker 4: needy are going to be worse off, and that's why
- 29:49Speaker 4: they reject it.
- 29:50Speaker 3: Yeah, And the other area where you see this view
- 29:55Speaker 3: is really at the time when modern medicine was coming
- 30:00Speaker 3: age in the nineteenth century, there was this view called
- 30:04Speaker 3: it's called also the republic of science view, which sounds
- 30:07Speaker 3: like a great name, but it's not a great idea.
- 30:09Speaker 3: And it's the idea that medical knowledge is kind of
- 30:13Speaker 3: like a public good and that's sure individuals contribute to it,
- 30:17Speaker 3: but no one owns it, right. And if that's the case,
- 30:22Speaker 3: and you kind of like downplay the role of bringing
- 30:27Speaker 3: that knowledge into practice, well then having businesses take that
- 30:32Speaker 3: kind of knowledge and create drugs from it looks wrong, right,
- 30:36Speaker 3: It's like, why are you doing that? We have this
- 30:40Speaker 3: a pool of medical knowledge for the benefit of humanity,
- 30:44Speaker 3: and you're putting a pattern on it and profiting off
- 30:47Speaker 3: of it. How dare you right? Which, of course it's
- 30:51Speaker 3: based on a false view, because yes, medical science and
- 30:55Speaker 3: science in general is a cooperative enterprise, but that enterprise
- 31:01Speaker 3: is only as good as the independent thinking of each
- 31:04Speaker 3: individual involves, right, And there is real individual value creation there,
- 31:11Speaker 3: which is why patents are appropriate. But also one of
- 31:13Speaker 3: the reasons why patents is were rejected within the medical
- 31:18Speaker 3: community because it was viewed that, well, you're essentially stealing
- 31:21Speaker 3: this public good. And there's an undermining also of the
- 31:26Speaker 3: role that businesses actually played in the history of medicine
- 31:29Speaker 3: in bringing drugs to market. And it is saying like, well,
- 31:33Speaker 3: it was just publicly funded, or even before it was
- 31:36Speaker 3: publicly funded, they would say it was this kind of comments.
- 31:42Speaker 2: So what do you think just doesn't exist.
- 31:44Speaker 1: Let's say in food, there's no big movement to nationalize
- 31:47Speaker 1: the food supply and nationalized food production.
- 31:51Speaker 2: But it definitely isn't healthcare.
- 31:55Speaker 1: I mean, it's much more socialism, if you will, egalitarian
- 32:00Speaker 1: as Amas described it, in healthcare. Then there is in
- 32:04Speaker 1: pretty much any other activity in the US today.
- 32:09Speaker 4: I think there probably is a little bit of that
- 32:11Speaker 4: in food, with food stamps and food banks and government
- 32:14Speaker 4: doing that. And there's definitely that when it comes to
- 32:15Speaker 4: like heating oil. You know, I'm talking to you from
- 32:17Speaker 4: Pittsburgh where it's ten degrees, but that there's always this
- 32:20Speaker 4: issue about heating oil, and there's all these programs to
- 32:23Speaker 4: make sure that people have heating well, so I think
- 32:25Speaker 4: it's there. I think medicine is just so stark because
- 32:27Speaker 4: it is life or death and it's now it's not
- 32:29Speaker 4: something it needs to many medical problems have to be
- 32:32Speaker 4: taken care of within days, hours, even minutes, So that's that.
- 32:37Speaker 4: I think the urgency of that is what brings it
- 32:39Speaker 4: to the for with medicine in a way that you
- 32:41Speaker 4: don't have time for another solution that you might have
- 32:43Speaker 4: with with food. But I think medicine kind of is
- 32:47Speaker 4: a hyperacute focus on that saying on that problem that
- 32:51Speaker 4: where altruism kind of directs people to.
- 32:53Speaker 5: Come up with there on. So this this.
- 32:55Speaker 4: Socialized solution, this universal solution versus versus free enterprise.
- 33:00Speaker 3: And I think it also has to do with how
- 33:04Speaker 3: doctors and people involved in medical innovation and the development
- 33:09Speaker 3: of medical knowledge, think of themselves as opposed to farmers
- 33:13Speaker 3: or people like that. And if they think of themselves
- 33:16Speaker 3: as you said earlier image as we're kind of above
- 33:19Speaker 3: all that, well, then the people that they interact with
- 33:23Speaker 3: the rest of society is going to hold them to
- 33:24Speaker 3: that kind of standard. Right. It's like, well, yeah, you
- 33:28Speaker 3: think that working with business is kind of beneath you,
- 33:33Speaker 3: then the expectation is like, well, create the knowledge and
- 33:37Speaker 3: we expect new drugs and new treatments.
- 33:42Speaker 1: Do you think people have an understanding of the extent
- 33:45Speaker 1: to which healthcare is produced is, you know, requires the
- 33:53Speaker 1: same kind of engagement activity as tech companies as any
- 34:00Speaker 1: other good that they are actually more so than any
- 34:03Speaker 1: of the good that they are consuming out there.
- 34:06Speaker 4: I think they recognize that healthcare workers do a lot.
- 34:09Speaker 4: I think that became very clear during COVID when people
- 34:11Speaker 4: were on this on their roofs clapping for the healthcare workers.
- 34:15Speaker 4: They know that you go through, especially for a physician,
- 34:18Speaker 4: you go through medical school and grueling, grueling residency and
- 34:21Speaker 4: long hours and you're basically committed to this for life
- 34:24Speaker 4: and you're constantly learning. So I think they recognize all
- 34:27Speaker 4: of that, and they recognize the long days and you know,
- 34:30Speaker 4: never not being able to answer to put your phone on,
- 34:33Speaker 4: do not disturb. They know all of that, but I
- 34:35Speaker 4: don't think they think of it as a product of
- 34:36Speaker 4: the mind.
- 34:37Speaker 5: They don't.
- 34:37Speaker 4: It's not as explicit to them as you know, you know,
- 34:40Speaker 4: to borrow one of your things like Steve Jobs creating
- 34:42Speaker 4: an iPhone. It's not it's not something that they think
- 34:44Speaker 4: of like that. They don't understand it's as a product
- 34:47Speaker 4: of a mind, that it is actually a product that's
- 34:48Speaker 4: being produced by an individual who's whether that's a doctor
- 34:52Speaker 4: or nurse, a dentist, what whoever it may be, or
- 34:53Speaker 4: a hospital or even a health insurance company.
- 34:55Speaker 5: They don't.
- 34:55Speaker 4: I don't think they they get that aspect of it.
- 34:58Speaker 4: They know that there's people there that that works hard
- 35:01Speaker 4: to get to those positions, but I don't think it's
- 35:03Speaker 4: as concrete to them as you know, someone that makes
- 35:06Speaker 4: an iPhone.
- 35:08Speaker 3: Yeah, and and and I think the dominant factor there
- 35:10Speaker 3: is that to the extent that they think it involves minds,
- 35:15Speaker 3: it's a collective mind, right, And if it is a
- 35:19Speaker 3: collective mind, then well that then you have to question
- 35:21Speaker 3: the kind of place for business, right, which is about
- 35:28Speaker 3: pursuing profits and taking something quote unquote taking something from
- 35:35Speaker 3: what people regard as this kind of public domain and
- 35:41Speaker 3: profiting off of it, right, and and that is for
- 35:45Speaker 3: you differently, And that's a problem because it is an
- 35:51Speaker 3: individual achievement. I mean, like, if you think of Amas,
- 35:56Speaker 3: who's the lady who came up with them or an
- 35:59Speaker 3: a vaccine Kitlyn Kirk, Kaitlin Karica on the wall, her
- 36:07Speaker 3: story is just amazing, right, Like she battled it out
- 36:12Speaker 3: against like all these other people who didn't believe in her.
- 36:16Speaker 3: I mean, you cannot tell me that what she achieves
- 36:22Speaker 3: was a personal individual achievement. Yes, it required work with
- 36:25Speaker 3: other people, and I think in those cases people might
- 36:30Speaker 3: appreciate the individual initiative and judgment involved, right and wing
- 36:36Speaker 3: with other people who were doing the same. But then
- 36:40Speaker 3: there's kind of like a pause. It's like, oh, but
- 36:44Speaker 3: that doesn't fit in with how I think about the
- 36:47Speaker 3: rest of science and medical science and my ideal view
- 36:50Speaker 3: that well, yeah, we don't want private businesses to develop
- 36:56Speaker 3: these drugs. We ideally would want someone else to do that,
- 37:00Speaker 3: someone who doesn't have a product motive, yep?
- 37:03Speaker 2: Did does it give them any pause?
- 37:06Speaker 1: The fact that you know an overwhelming majority of medical
- 37:09Speaker 1: innovation happens in the United States because it's still a
- 37:14Speaker 1: little bit there's still some elements of freedom, and there
- 37:16Speaker 1: is a profit motive at least driving farm a biotech
- 37:21Speaker 1: and some of these, some of these entities.
- 37:25Speaker 5: I think most of them evade that that aspect of it.
- 37:27Speaker 4: That's why, and even the people here evade that aspect
- 37:30Speaker 4: that the policymakers who know better evate it. That's why
- 37:33Speaker 4: when they do medicare quote, you know, price negotiation.
- 37:36Speaker 5: Which is not really a negotiation.
- 37:38Speaker 4: When they do that, they don't realize that prices are
- 37:41Speaker 4: higher in the United States because that's subsidizing all of
- 37:43Speaker 4: the research that the rest of the world, which does
- 37:45Speaker 4: have price controls.
- 37:46Speaker 5: So I don't I don't think they understand.
- 37:48Speaker 4: I think they know that the innovation is occurring in
- 37:50Speaker 4: the United States, that the that the most the cutting
- 37:53Speaker 4: almost all the cutting edge stuff happens here. But I
- 37:55Speaker 4: don't think that they they recognize that it's because of
- 38:00Speaker 4: people's ability to gain to profit from it, that that
- 38:03Speaker 4: that is what's driving that. I think that maybe some
- 38:08Speaker 4: they understand that a little bit with the pharmaceutical industry,
- 38:09Speaker 4: but they but I think it's it's very limited, and
- 38:12Speaker 4: they don't understand the consequences of when they make it
- 38:16Speaker 4: inhospitable to that type of innovation. That investment money is
- 38:20Speaker 4: not going to go to pharmaceutical companies if pharmaceutical companies
- 38:23Speaker 4: can't give people a good return.
- 38:26Speaker 3: Now, I think from the European side, why it might
- 38:30Speaker 3: not give them pause is because what's more important in
- 38:34Speaker 3: their minds is not the newest thing, but does everyone
- 38:39Speaker 3: have the same right? And if that's your primary concern,
- 38:44Speaker 3: you're going to be less concerned about something new, right
- 38:47Speaker 3: because by definition, something new is going to be limited,
- 38:52Speaker 3: and so you're not gonna that's not going to be
- 38:55Speaker 3: your top of mind if your primary concern is like, well,
- 38:59Speaker 3: we just want everyone to the same.
- 39:01Speaker 4: There are people now that even openly advocate if some
- 39:03Speaker 4: some new treatment, even if it's if it's breakthrough and
- 39:07Speaker 4: in curative, if it's cost too much and not everybody
- 39:09Speaker 4: can have it, we shouldn't even develop it. So that's
- 39:12Speaker 4: also something this kind of trial balloon has kind of
- 39:16Speaker 4: gone up about this this idea that if you make
- 39:18Speaker 4: some drug that cures Alzheimer's disease and it costs too
- 39:22Speaker 4: much and not everybody's going to have it then just
- 39:23Speaker 4: it shouldn't be something that you can worry about.
- 39:26Speaker 2: Right, So it's pretty bleak. The state of healthcare is.
- 39:34Speaker 1: Bleak, particularly when I think we know what alternatives could
- 39:36Speaker 1: be and how good it could be. Uh, but people's
- 39:40Speaker 1: attitudes is even bleaker than the than the state of
- 39:42Speaker 1: the of of of the of the field.
- 39:46Speaker 2: Is how do we how do we change this? How
- 39:48Speaker 2: do you make a dent in what's going on right now?
- 39:51Speaker 3: I mean, I think what you would have to do.
- 39:54Speaker 3: I mean that the bottom line is that we live
- 39:57Speaker 3: in a time that's actually pretty exciting for or medical innovation,
- 40:02Speaker 3: and even with regards to the delivery of healthcare, the
- 40:06Speaker 3: people coming up with new ideas like they might not
- 40:09Speaker 3: always work, but there's a lot of reasons to be
- 40:14Speaker 3: excited about medicine. And what you would want to do
- 40:17Speaker 3: then is then appeal to the best of people, in
- 40:23Speaker 3: terms of people who actually want to create new things,
- 40:27Speaker 3: and instill with them that healthcare is a product of
- 40:32Speaker 3: the mind that is worth fighting for, and that it's
- 40:35Speaker 3: not only worth fighting for the doctor or to insure
- 40:39Speaker 3: or the people working in big pharma, but for everyone,
- 40:43Speaker 3: which is not a perspective that you tend to have.
- 40:46Speaker 3: You tend to have people throwing each other under the bus, like, oh,
- 40:49Speaker 3: it's their fault, it's their fault. You need a recognition
- 40:52Speaker 3: that what you're creating is valuable and it requires freedom,
- 40:55Speaker 3: but not just for you before everyone else. And that's
- 40:58Speaker 3: a long term goal. But I think that's due, especially
- 41:00Speaker 3: given that people are so excited about health care, and
- 41:04Speaker 3: if they sense that whatever they're working on is under threats,
- 41:10Speaker 3: that's where we can come in and be like, no,
- 41:11Speaker 3: like this is worth defending, and we're going to give
- 41:13Speaker 3: you the intellectual ammunition to do that.
- 41:17Speaker 4: And I think it emphasizing that medicine is a product
- 41:19Speaker 4: of the mind, and the mind needs to be free
- 41:21Speaker 4: in order to be able to flourish. And if you
- 41:24Speaker 4: want the best health care, if you want the best medicine,
- 41:25Speaker 4: you've got to make sure that those minds are free
- 41:28Speaker 4: and not subject to force from all. You know, all
- 41:31Speaker 4: against all, of war against all against all, basically is
- 41:35Speaker 4: what's going on in healthcare. I think you've got to
- 41:37Speaker 4: get people to really understand that at a concrete level,
- 41:40Speaker 4: and then they see what the possibilities could be, and
- 41:43Speaker 4: then I think that's how you introduce them to what
- 41:45Speaker 4: a free market looks like, that all these caricatures are wrong,
- 41:48Speaker 4: that we don't have a free market, and what they
- 41:50Speaker 4: worry about is not necessarily going to be some major
- 41:53Speaker 4: disqualifying problem.
- 41:57Speaker 1: Should you, guys think that what Alex has done in
- 42:01Speaker 1: the field of energy can be done here, Alex Epstein
- 42:04Speaker 1: could be done here in healthcare?
- 42:06Speaker 2: To what extent do you think?
- 42:07Speaker 5: You know?
- 42:08Speaker 1: Objectivism has to win in the culture for there to
- 42:10Speaker 1: be fundamental changes in healthcare.
- 42:14Speaker 4: I think Alex is a good I think Alex is
- 42:17Speaker 4: a good example of how this could work. I think
- 42:19Speaker 4: that you could apply almost you could almost just transpose
- 42:22Speaker 4: a lot of his talking points to healthcare because and
- 42:25Speaker 4: I think it would work. And I think he's his
- 42:27Speaker 4: ability to do it in a way that's non confrontational,
- 42:30Speaker 4: that actually gets people to be really honest about what
- 42:33Speaker 4: they're worried about and talk about their concerns and show
- 42:36Speaker 4: the right way. I think would work. And I don't
- 42:38Speaker 4: necessarily think objectivism has to win in the culture to
- 42:41Speaker 4: get this. I think once you start to get it
- 42:44Speaker 4: actually a real element of free enterprise, I think people
- 42:47Speaker 4: will start to see the difference. I mean, you know,
- 42:50Speaker 4: you know, Canadians, even if they like to not say
- 42:52Speaker 4: that they see the difference, they do see the difference
- 42:54Speaker 4: because go look at that hospital Niagara Falls in New York.
- 42:57Speaker 4: How many Canadians go there and how many you know,
- 42:59Speaker 4: how many many people live near You have US insurance
- 43:02Speaker 4: that live in Canada, just in case. But so I
- 43:04Speaker 4: think that that's one way to think about it, is
- 43:07Speaker 4: what Alex did. I think it would be you know,
- 43:09Speaker 4: great if Ray could be the Alex for healthcare. That's
- 43:12Speaker 4: one of the hopes with you know, Ray being executive
- 43:14Speaker 4: director and all the work riis doing to help with this.
- 43:19Speaker 3: I mean, Alex is definitely an inspiration for me, and
- 43:23Speaker 3: there's a lot to learn there, but there's also differences
- 43:29Speaker 3: in healthcare. I mean, the what what Alex has shown
- 43:37Speaker 3: to people through his work is that environmentalism is essentially
- 43:41Speaker 3: based on an anti human disposition attitude, right, and people
- 43:48Speaker 3: recognize that that's wrong. But it's harder to show that
- 43:52Speaker 3: something like egalitarianism is wrong. It's still wrong, Like you
- 43:56Speaker 3: could still end up showing that it's monstrous, but it
- 43:59Speaker 3: requires more work, it's more ingrained, and more importantly, again,
- 44:02Speaker 3: there's this certain ethical ethos around medicine. That makes it
- 44:08Speaker 3: harder to make a moral case for free markets in it.
- 44:12Speaker 3: So what you would really need, like really even before
- 44:16Speaker 3: you convince everyday Americans, is that you would have to
- 44:19Speaker 3: convince doctors to rethink their own image, and not just doctors,
- 44:26Speaker 3: other producers in healthcare, people working in the pharmaceutical industry, pharmacists, scientists,
- 44:31Speaker 3: nurses rethink their own moral self image in a way
- 44:36Speaker 3: that's very counterintuitive to most people. But it can be done.
- 44:42Speaker 3: And there are many people who do view themselves in
- 44:48Speaker 3: medicine as doing business and that that's good, that that's
- 44:51Speaker 3: just and I see no reason why we can't accomplish
- 44:55Speaker 3: that long term.
- 44:56Speaker 1: Yeah, I mean, there's definitely one difference is that the
- 44:59Speaker 1: people within the n industry generally support the profit motive
- 45:03Speaker 1: and it generally pro business and always have been. So
- 45:07Speaker 1: Alex started with a base of support from within the
- 45:09Speaker 1: industry that maybe doesn't quite exist in healthcare though, you know,
- 45:13Speaker 1: maybe maybe you can start with the businesses that those
- 45:18Speaker 1: new doctors and maybe with some of the biotech medical devices,
- 45:23Speaker 1: pharma uh that are already based on bis on the
- 45:26Speaker 1: profit motive, that that is a good beginning.
- 45:29Speaker 5: Yeah, And I definitely have tried to do that with pharma.
- 45:31Speaker 4: Anytime I get interviewed and asked about COVID vaccines or
- 45:34Speaker 4: the patents or whatever it might be, I've been trying
- 45:36Speaker 4: to do like many Alex uh types of you know,
- 45:41Speaker 4: getting across kind of miny Alex type of points to
- 45:44Speaker 4: the press when I'm talking about you know who actually
- 45:46Speaker 4: turns a vaccinate, a vaccine into a vaccination that gets
- 45:48Speaker 4: in someone's arms.
- 45:49Speaker 5: It's the pharmaceutical companies.
- 45:50Speaker 4: And especially when we have you know, an incoming health
- 45:54Speaker 4: potential health secretary that's really against all these pharmaceutical companies.
- 45:58Speaker 4: I think it's really important to defend pharmace citical companies
- 46:00Speaker 4: as being you know that they saved the world when
- 46:02Speaker 4: it came to COVID.
- 46:03Speaker 3: Absolutely, And that is definitely, uh the way that I
- 46:08Speaker 3: see the role for for afgandist for different people in
- 46:13Speaker 3: the healthcare industry, providing intellectual ammunition ways to defend themselves
- 46:19Speaker 3: against unjust attacks and to defend the work that they
- 46:23Speaker 3: do in not just practical for the moral terms.
- 46:28Speaker 1: Yeah yeah, I mean, I mean the challenge seems to
- 46:31Speaker 1: be these days twofold in medicine. Not only do you
- 46:33Speaker 1: have the moral obstacles. But then you have, you know,
- 46:37Speaker 1: the whole crazy anti science segment of the American public
- 46:42Speaker 1: that is turning against vaccines and against healthcare and if
- 46:46Speaker 1: emactin will kill cancer according to the prominent scientist Mel Gibson.
- 46:53Speaker 2: You know you've got to you've got more quackery. Although
- 46:56Speaker 2: I guess you have the same thing with climate science.
- 47:00Speaker 3: I mean, I think that that is closer to the
- 47:02Speaker 3: phenomena that Alex is dealing with that. I mean there's
- 47:05Speaker 3: a kind of environmentalist aspect to that that untouched nature,
- 47:11Speaker 3: like untouched human bodies are healthier than vaccinated ones.
- 47:19Speaker 4: Yeah, I will say an untouched human body is going
- 47:21Speaker 4: to live about twenty years, that's right.
- 47:24Speaker 2: Yes.
- 47:25Speaker 1: And the last I look that I vi mectin was
- 47:26Speaker 1: not untouched by humans, even i Vimectin is a drug that.
- 47:30Speaker 5: Was developed made by Mark Pharmaceuticals.
- 47:33Speaker 2: Yeah, so.
- 47:36Speaker 1: You know it's just for whatever bizarre, crazy reason, it
- 47:39Speaker 1: has become the cure for a certain.
- 47:43Speaker 2: Segment of the population. It is truly bizarre. So yeah, good.
- 47:49Speaker 3: I mean that it does show the kind of integration
- 47:54Speaker 3: of knowledge that we need, Like we don't just need
- 47:57Speaker 3: people saying that well pharmacy, the cool companies aren't evil.
- 48:01Speaker 3: We need people with that perspective pushing back against this
- 48:06Speaker 3: kind of ignorance, but also a real need for knowledge,
- 48:09Speaker 3: like people are wondering what things in the environments are
- 48:13Speaker 3: potentially harmful for me? Like, well, what things should I
- 48:16Speaker 3: which is a real value? And so we really need
- 48:19Speaker 3: a strong integration of philosophical knowledge and expertise across all
- 48:26Speaker 3: these disciplines.
- 48:27Speaker 1: How do you deal with the fact that so many
- 48:31Speaker 1: people today attribute the success in medicine to government, So
- 48:36Speaker 1: it's government funds, it's n H grants, Pharma is in
- 48:43Speaker 1: bed with government. They could really do what they do without,
- 48:46Speaker 1: you know, the cronyism. How do we separate out what
- 48:49Speaker 1: are real achievements of kind of the whatever is private
- 48:54Speaker 1: and what.
- 48:56Speaker 2: People attribute to government.
- 48:58Speaker 4: I think it's very difficult because it's is completely integrated now.
- 49:01Speaker 4: The NIH works hand in glove with pharmaceutical companies. The
- 49:04Speaker 4: NIH works on the COVID vaccine, handed off that flumulative
- 49:06Speaker 4: majerna that that you know, there are real genuine scientists
- 49:09Speaker 4: that work at NIH, and the government is basically crowded
- 49:13Speaker 4: out a lot of the basic science research budget for
- 49:16Speaker 4: decades now, So right now it is very difficult to
- 49:20Speaker 4: separate it, but there clearly are demarcations where you can
- 49:22Speaker 4: see who does the work they and sometimes there are
- 49:24Speaker 4: fights over patents. That just was one between NIH and Maderna.
- 49:28Speaker 4: They But I think you have to realize that we
- 49:30Speaker 4: live in a system where government is involved in all
- 49:32Speaker 4: aspects of biomedical research as well as the delivery of healthcare.
- 49:37Speaker 5: So it's impossible to completely untangle them.
- 49:40Speaker 4: And there are genuine scientists that work at the NIH,
- 49:43Speaker 4: that work at CDC, that work at FDA, that are
- 49:45Speaker 4: part of that team. But I think you have What
- 49:47Speaker 4: you have to realize is that there's still a commercial aspect.
- 49:50Speaker 4: There's building it in scales, turning an idea into a product,
- 49:53Speaker 4: And I think there's where some of that.
- 49:55Speaker 5: That's where you can kind of separate some of that.
- 49:57Speaker 4: And also there are things genuine discoveries happen at pharmaceutical companies,
- 50:01Speaker 4: But you have to it's kind of what's on the scene.
- 50:03Speaker 4: You don't know what it would be like if there
- 50:05Speaker 4: weren't an if NIH wasn't the major funder of basic
- 50:07Speaker 4: science research, we don't know how many other philanthropies would
- 50:10Speaker 4: do this. Remember, you know the polio vaccine was founded
- 50:13Speaker 4: was funded by a private charity, the March of Dimes.
- 50:15Speaker 4: It wasn't funded by government, so there is there are
- 50:18Speaker 4: examples of non governmental funding doing that. And the Bill
- 50:21Speaker 4: of mil Indigates Foundation is another great example of the
- 50:24Speaker 4: innovations that they're doing with genetically modified mosquitos and all
- 50:27Speaker 4: kinds of cool stuff.
- 50:29Speaker 1: Yeah, phony they were allowed to actually get those out.
- 50:32Speaker 1: I'd love to see the death of mosquitos.
- 50:36Speaker 3: And I mean and there are also people who are
- 50:40Speaker 3: frustrated with like how the NIH funds particular kinds of research,
- 50:46Speaker 3: and they're trying to come up with new models for funding. Right,
- 50:51Speaker 3: so there's like a base there that you can show
- 50:53Speaker 3: that we can you can also have basic science work
- 51:00Speaker 3: being funded outside of the government, but like Amachell, it's
- 51:03Speaker 3: very difficult because it's crowded out and if the brightest
- 51:07Speaker 3: minds to see their mentors or working at the NIH
- 51:12Speaker 3: or these and it's kind of seen as the highest
- 51:18Speaker 3: kind of funding that you can get is an NIH grant,
- 51:20Speaker 3: Like if you're at like a even a private university,
- 51:25Speaker 3: then that's what people are going to do. But like
- 51:27Speaker 3: you mentioned in the previous show, you're on the problem
- 51:29Speaker 3: with that is that very often it's these older people
- 51:31Speaker 3: that are getting it. And if people see that as
- 51:34Speaker 3: like a symptom of a wider problem, well they're probably
- 51:38Speaker 3: not going to say like, oh, we have to be
- 51:41Speaker 3: funded an IH or privatize it or whatever, but they
- 51:44Speaker 3: might at least be open to reforms, which is the
- 51:46Speaker 3: first step.
- 51:49Speaker 1: Yeah, there seems to be a growing movement to try
- 51:52Speaker 1: to reform at least an IH to make a science
- 51:56Speaker 1: funding more effective. We'll see how far that goes. But
- 51:59Speaker 1: this used to be at least voices talking about it.
- 52:01Speaker 1: Who are many of them from the from economics. So
- 52:09Speaker 1: what do you guys expect in the in the in
- 52:11Speaker 1: the next few years that AFCOME is going to be
- 52:15Speaker 1: doing concretely to make some of these changes.
- 52:21Speaker 2: I mean.
- 52:24Speaker 3: Changes are definitely long term, Like if by changes you
- 52:28Speaker 3: mean policies, And importantly we are an educational organization, so
- 52:33Speaker 3: we don't directly advocate for policy changes. We also can
- 52:36Speaker 3: endorse candidates any of that stuff. We educate people about
- 52:42Speaker 3: policies so they can support them an advocate for them themselves.
- 52:48Speaker 3: But I think before you would do that and we
- 52:52Speaker 3: will continue to do that, and you would really want
- 52:55Speaker 3: to connect with particular communities within the healthcare system and
- 53:00Speaker 3: speak to their concerns and again, like I said, to
- 53:04Speaker 3: the best aspects of them, to the aspects that recognizes
- 53:08Speaker 3: that the work that they're doing is important, and then
- 53:11Speaker 3: that creates an opening that if that work is being
- 53:14Speaker 3: threatened in some way by government regulations or controls, you
- 53:18Speaker 3: can say, well, the reason why it's being threatened is
- 53:21Speaker 3: because you're under force and you need freedom. And you
- 53:25Speaker 3: would want to build a kind of a relationship with
- 53:28Speaker 3: those communities, not unlike Alex has done with the fossil
- 53:30Speaker 3: fuel industry, that you're their ally, you're an intellectual advocate
- 53:36Speaker 3: for them, and then you would want to start doing
- 53:39Speaker 3: that across communities in order to build a broad coalition
- 53:44Speaker 3: or alliance.
- 53:45Speaker 4: And I think a couple of concrete things we want
- 53:48Speaker 4: to happen is we want Ray to start being involved
- 53:50Speaker 4: in policy discussions, going to Washington and being in part
- 53:54Speaker 4: of panel discussions and that other thing tanks might be
- 53:56Speaker 4: having writing speaking about this. He's also convening a lot
- 54:00Speaker 4: of doctors that are kind of in the objective is
- 54:03Speaker 4: Ari orbit that have kind of that We've been collecting
- 54:07Speaker 4: their names, and we have this call every couple of
- 54:10Speaker 4: weeks called the Thomas Hendricks Working Group, named after Thomas Hendricks,
- 54:13Speaker 4: the physician and Atlas Shrugg.
- 54:15Speaker 5: So we've been doing that kind of stuff.
- 54:16Speaker 4: It's kind of slow going now because we're trying to
- 54:18Speaker 4: just get everything up and running. But I think what
- 54:21Speaker 4: what I want Affkam to do is be part of
- 54:23Speaker 4: the policy discussion that's going on and be a real
- 54:26Speaker 4: player and people say, you know, what's Affcam's view on
- 54:28Speaker 4: this position. That's what where I think we would make
- 54:30Speaker 4: some headway even if we don't see a specific policy change,
- 54:33Speaker 4: but being able to talk to and influence people that
- 54:36Speaker 4: are thinking about these policies and putting them in the
- 54:38Speaker 4: right moral framework, not just as you know, quick fixes
- 54:41Speaker 4: that are going to be undone by the next administration,
- 54:43Speaker 4: or you know, just tinkering with you know, the Healthcare
- 54:45Speaker 4: Savings Account contribution amount goes up by five hundred dollars,
- 54:49Speaker 4: so you know that's not we're not trying to do that.
- 54:52Speaker 1: So if there's a doctor out there listening to the
- 54:55Speaker 1: show who would like to participate in some of these
- 54:59Speaker 1: calls and involved in what you guys are trying to do,
- 55:02Speaker 1: how do they how do they get in touch with you?
- 55:04Speaker 5: What do you?
- 55:05Speaker 2: What do you? What can they do?
- 55:07Speaker 3: Uh? In the show description there's a link to ww
- 55:12Speaker 3: dot FM dot org and there is my email under people.
- 55:17Speaker 3: I can also just tell them what my email is.
- 55:20Speaker 3: It's our sEH you you are at a f CM
- 55:25Speaker 3: dot org.
- 55:26Speaker 4: And importantly, it's not just doctors. If there's dentists, physical therapists, optometrists, psychologists,
- 55:32Speaker 4: anybody in any of the allied health field, nurses, anybody
- 55:35Speaker 4: that's interested in this where where we want to be
- 55:37Speaker 4: part of this. It's not something exclusively to physicians. It's
- 55:40Speaker 4: it's really anybody in the whole ecosystem of healthcare, pharmaceuticals, biotech, pharma,
- 55:45Speaker 4: all of that. That's kind of what we want to
- 55:48Speaker 4: try to attract the people that are interested in these
- 55:49Speaker 4: ideas and want to learn more or want to participate
- 55:51Speaker 4: in some of our stuff.
- 55:52Speaker 2: So the best thing then is do I is to
- 55:54Speaker 2: send way in email expressing that interest. Great.
- 55:58Speaker 1: I also got Wes's here. Wes, thank you for the support.
- 56:02Speaker 1: Really appreciated, he says, I got here late. I appreciate
- 56:05Speaker 1: your efforts. How can any of us contribute to help?
- 56:09Speaker 2: Say?
- 56:09Speaker 1: Is there a way to contribute online? Or again, should
- 56:12Speaker 1: they contact you, Ray.
- 56:16Speaker 3: You can go to our website where we have a
- 56:19Speaker 3: donation page, and if you want to make a recurring donation,
- 56:23Speaker 3: you can send me an email.
- 56:25Speaker 1: So a f CM dot org, f CM dot com,
- 56:29Speaker 1: FCM dot org is basically the website. You can check
- 56:32Speaker 1: it out and then drop drop away an email, particularly
- 56:37Speaker 1: if you're in the health fields, any of the health fields.
- 56:42Speaker 1: If you're in biotech. I know a number of my
- 56:43Speaker 1: listeners in biotech, or if you're a scientist, or if
- 56:46Speaker 1: you're doctor, nurse, or any anybody related in the in
- 56:51Speaker 1: these fields, this is the time to get involved and.
- 56:55Speaker 5: And and then will be in Florida at the conference
- 56:58Speaker 5: and Fort Myers.
- 56:59Speaker 1: Okay, that's right. And the confidence in Naples, what is
- 57:04Speaker 1: the next week? Late next week is happening and Emass
- 57:09Speaker 1: and Ray are going to be there, so they're escaping
- 57:11Speaker 1: the cold of the Northeast. You guys should escape the
- 57:13Speaker 1: colds in the Northeast and come down to Naples, Flada
- 57:17Speaker 1: and hang out with us over Iinman's birthday.
- 57:19Speaker 2: It should be a lot of fun.
- 57:21Speaker 3: Right.
- 57:21Speaker 1: Let's see, we've got a few questions here. Let's see
- 57:28Speaker 1: Jennifer asks, why do you think so many non medical
- 57:31Speaker 1: people think they know about medicine when they don't. I
- 57:35Speaker 1: don't usually hear non engineers thinking they know all about
- 57:39Speaker 1: bridge construction.
- 57:41Speaker 4: I think it's probably because people have some experience with
- 57:44Speaker 4: their own health. They've doctored themselves, they figured some they've
- 57:47Speaker 4: learned some things basic first, and they kind of extrapolate that,
- 57:51Speaker 4: especially when they've got resources like the Internet where they
- 57:53Speaker 4: can look things up and get some expert opinions. So
- 57:55Speaker 4: I think it's because this is something they directly have
- 57:57Speaker 4: experience with. It's not like they're building a bridge every day,
- 58:00Speaker 4: but they're dealing with their aches and pains and sniffles
- 58:02Speaker 4: every day. So I think that's that familiarity plus resources
- 58:05Speaker 4: that are available on the Internet.
- 58:07Speaker 1: Do you think it's also the fact that there's disagreement
- 58:10Speaker 1: in the field, Like there's not a lot of disagreement
- 58:12Speaker 1: publicly at least about a bridge, about how construct a
- 58:15Speaker 1: bridge and what goes into it, but on healthcait seems
- 58:19Speaker 1: like there's contradictor information almost every day that is made public,
- 58:23Speaker 1: so the experts don't agree.
- 58:25Speaker 4: Put it that way, Yeah, I think there definitely are
- 58:27Speaker 4: certain areas where there is controversy where there could be
- 58:30Speaker 4: two groups of really well and you know, two groups
- 58:33Speaker 4: of subject matter experts that completely disagree on something like,
- 58:35Speaker 4: for example, Alzheimer's disease, what causes aime. There's lots of that,
- 58:38Speaker 4: So that also creates there's not certainty the way there is,
- 58:41Speaker 4: like you said, with you know, the principles of engineering
- 58:43Speaker 4: to build a bridge. So that also opens up that
- 58:46Speaker 4: idea that nobody knows. Nobody's an expert, they don't know.
- 58:50Speaker 4: And there are places where it's really bad in medicine,
- 58:52Speaker 4: like nutrition, where I think that you can ever figure
- 58:54Speaker 4: up or down in nutrition, but I think that that's
- 58:58Speaker 4: what leads to it.
- 59:00Speaker 1: And yet, and yet we've got plenty of religionists when
- 59:02Speaker 1: it comes to nutrition. Nutrition is a is an open
- 59:05Speaker 1: field for these people who who know the truth, and
- 59:08Speaker 1: there's no question about what that truth is in spite
- 59:12Speaker 1: of the ambiguity of the science.
- 59:15Speaker 2: Yes it is. It is a unique field. And I
- 59:17Speaker 2: think you're I think you're right.
- 59:18Speaker 1: It's our familiarity with our own bodies and own challenges
- 59:21Speaker 1: that makes it that we think from end of one
- 59:24Speaker 1: we can extrapolate to what is true and what is
- 59:26Speaker 1: not U and even one is dubious, right when.
- 59:29Speaker 4: You think about like the old man who says it's
- 59:31Speaker 4: going to rain because I can feel it in my knee.
- 59:32Speaker 4: I mean, that's been going on forever where people have
- 59:34Speaker 4: these these ideas about their health and yep.
- 59:40Speaker 1: Marion Lene asks, are they ways for better, more experienced
- 59:43Speaker 1: doctors to get paid more. Many seem to think doctors
- 59:47Speaker 1: are interchangeable, but they're not. It's hard to get information
- 59:51Speaker 1: about which doctors are better. And then she says, PS
- 59:55Speaker 1: Medicare sucks.
- 59:58Speaker 4: I think it's it's really really hard for doctors to
- 1:00:00Speaker 4: get paid more because it's the same fee schedule. So
- 1:00:02Speaker 4: if you do an appendectomy, you're going to get it
- 1:00:04Speaker 4: based on You're going to get paid whatever it is,
- 1:00:07Speaker 4: based on your given area that you live in that
- 1:00:09Speaker 4: the insurance company says, this is what healthcare costs here.
- 1:00:11Speaker 4: So no, you don't really have the ability to get
- 1:00:13Speaker 4: paid more unless you're doing something on the side, like
- 1:00:15Speaker 4: a plastic surgeon or somebody that's doing something outside of
- 1:00:18Speaker 4: the insurance industry, or you go to your hospital if
- 1:00:21Speaker 4: you're employed by a hospital, say you know, I'm the
- 1:00:23Speaker 4: best at such and such a thing.
- 1:00:24Speaker 5: I want to be paid more.
- 1:00:25Speaker 4: They may pay you more that way, but the insurance
- 1:00:27Speaker 4: company is not really going to pay They may pay
- 1:00:29Speaker 4: you give you a little bonus for quality or less errors,
- 1:00:32Speaker 4: that kind of thing, but it's not going to be
- 1:00:34Speaker 4: it's not it's very hard to really get a different
- 1:00:38Speaker 4: salary based on that and the US system. It's interesting,
- 1:00:41Speaker 4: you know, and US doctors everything, but he thinks that
- 1:00:43Speaker 4: paid the highest. It's actually Switzerland doctors are paid higher
- 1:00:46Speaker 4: on average than in the United States, and Canada is
- 1:00:48Speaker 4: not very far behind US doctors in terms of pay,
- 1:00:51Speaker 4: even though those are socialized systems.
- 1:00:54Speaker 2: So is the only way if an American doctor to
- 1:00:55Speaker 2: make more money is to increase volume.
- 1:00:58Speaker 4: Yes, it's basically to increase volume or you know, yeah,
- 1:01:01Speaker 4: I guess increased volume, or do something outside the system
- 1:01:04Speaker 4: that they're allowed to do. Sometimes they'll pay for quality,
- 1:01:08Speaker 4: like an insurance company will give you a bonus if
- 1:01:09Speaker 4: you've had you know, less postop infections or whatever, or
- 1:01:12Speaker 4: if you got all your diabetic patients or under. They'll
- 1:01:15Speaker 4: look at the whole panel and say, well, this guy's
- 1:01:17Speaker 4: got all this patients under really well controlled. We'll give
- 1:01:19Speaker 4: you a little bit of a more. But that's kind
- 1:01:20Speaker 4: of like an add on bonus, not really, you know,
- 1:01:23Speaker 4: you're not charging anybody more.
- 1:01:26Speaker 2: Think do you think in a free market, what do
- 1:01:28Speaker 2: you think the model would.
- 1:01:30Speaker 1: Evolve to in a free market, because it seems like
- 1:01:32Speaker 1: this model and the way doctors are paid is insane today.
- 1:01:37Speaker 4: I think it would probably move. I think you probably
- 1:01:39Speaker 4: have lots of different ways. There might be things that
- 1:01:42Speaker 4: look very similar to what we have today where people
- 1:01:44Speaker 4: have insurance and they have a doctor and that doctor
- 1:01:46Speaker 4: is employed by a hospital system. But I think what
- 1:01:48Speaker 4: you would see is a lot more people outside the system,
- 1:01:50Speaker 4: a lot more cash business or people pre paying subscription
- 1:01:54Speaker 4: type of models where they're able to avoid all those insurance,
- 1:01:59Speaker 4: more people with catastrophic health insurance rather than insurance that's
- 1:02:02Speaker 4: kind of you know that covers everything. All of those
- 1:02:05Speaker 4: types of models would probably be different, I think. I
- 1:02:09Speaker 4: mean it would be interesting to look at, you know,
- 1:02:10Speaker 4: for example, pet insurance that's becoming a big thing now
- 1:02:13Speaker 4: where they have a free market. Veterinarians make more than
- 1:02:15Speaker 4: doctors for the for than medical doctors. But the head
- 1:02:18Speaker 4: insurance is an area where there might you might see
- 1:02:20Speaker 4: the innovation there and I know people would probably cringe
- 1:02:23Speaker 4: it trying to make that kind of comparison, but I
- 1:02:25Speaker 4: think that's where you're going to probably see innovative models
- 1:02:28Speaker 4: in places where they're able.
- 1:02:30Speaker 1: To do it.
- 1:02:32Speaker 3: Yeah, And what's interesting is that if you look at
- 1:02:35Speaker 3: the history of healthcare, insurance models initially didn't want to
- 1:02:40Speaker 3: get involved at all, and it was really because the
- 1:02:43Speaker 3: AMA went after physician group practices that the insurance model
- 1:02:49Speaker 3: is the only game left in town. And at that
- 1:02:52Speaker 3: point there was federal legislation being pushed. This was during
- 1:02:57Speaker 3: the nineteen thirties, and then the idea was, well, now
- 1:03:00Speaker 3: we have to work with insurance companies because otherwise we're
- 1:03:02Speaker 3: going to have a national health insurance model. And if
- 1:03:09Speaker 3: you look at the history like it gives you a
- 1:03:12Speaker 3: sense of how different things could have been if that
- 1:03:17Speaker 3: original burgeoning of different models for financing healthcare was allowed
- 1:03:20Speaker 3: to actually continue.
- 1:03:23Speaker 4: Initially, insurance was just going to be for hospitals, hospitals
- 1:03:26Speaker 4: with charge insurance companies for this day, and the doctors
- 1:03:28Speaker 4: were just going to pay you be paid cash by
- 1:03:30Speaker 4: the patient. And then they became kind of something where
- 1:03:34Speaker 4: they got it kind of got captured by the whole
- 1:03:36Speaker 4: insurance and just that that whole thing happened as a
- 1:03:38Speaker 4: way to stave off complete nationalization.
- 1:03:41Speaker 1: What are your thoughts on like Peter TIA's views on
- 1:03:46Speaker 1: healthcare three point zero, that is the next evolution kind
- 1:03:48Speaker 1: of in healthcare.
- 1:03:50Speaker 5: I like Peter A.
- 1:03:51Speaker 3: Tia.
- 1:03:51Speaker 4: I did his podcast early on in COVID. I think
- 1:03:53Speaker 4: it was one of my better interviews of one of
- 1:03:54Speaker 4: the better interviews I did, not excluding my interviews with you.
- 1:03:58Speaker 4: But I think he's onto some very interesting ideas. I
- 1:04:02Speaker 4: think that increasingly this preventative medicine thinking about longevity and
- 1:04:08Speaker 4: the health span versus lifespan is taking over the way
- 1:04:13Speaker 4: that people.
- 1:04:13Speaker 5: Are thinking about this.
- 1:04:14Speaker 4: I think what we need is a lot more innovation
- 1:04:15Speaker 4: and understanding aging and understanding what things to do.
- 1:04:19Speaker 5: There's still a lot of controversy over what works, what
- 1:04:21Speaker 5: doesn't work.
- 1:04:22Speaker 4: And then I think some of the stuff he does
- 1:04:24Speaker 4: is very It's very hard to adhere to all of
- 1:04:26Speaker 4: the stuff he does in terms of the weight training
- 1:04:29Speaker 4: and all of the exercise. That's very difficult to do
- 1:04:31Speaker 4: for a lot of people. So I don't know that
- 1:04:33Speaker 4: everybody's going to adopt everything, but I think it is
- 1:04:35Speaker 4: really promising stuff, and I think he's got very very
- 1:04:37Speaker 4: good ideas and deserves a lot more attention than he gets,
- 1:04:41Speaker 4: and I think maybe research will finally we'll catch up
- 1:04:44Speaker 4: to that eventually.
- 1:04:46Speaker 2: Y that'd be great.
- 1:04:47Speaker 1: Yeah, I'm definitely definitely a fan of the work that
- 1:04:50Speaker 1: he does, all right, and once has history amish. You
- 1:04:57Speaker 1: said we need to shut down because we didn't test
- 1:05:01Speaker 1: soon enough. But did you also think the emergency was
- 1:05:04Speaker 1: winding down in February twenty twenty.
- 1:05:08Speaker 4: Okay, I never said that we needed shutdowns. I said
- 1:05:11Speaker 4: the shutdowns occurred because there was no because hospitals got
- 1:05:15Speaker 4: overwhelmed and there was no way to know who was
- 1:05:17Speaker 4: sick and who wasn't, and governor's panicked. They think, if
- 1:05:20Speaker 4: you can look at some of the talks I gave,
- 1:05:22Speaker 4: I gave one at OCONN in Austin where I go
- 1:05:24Speaker 4: through this in great detail. But I never have thought
- 1:05:25Speaker 4: shutdowns are necessary. I was advocating a Taiwan South Korea
- 1:05:29Speaker 4: approach from the very beginning. YEP, test trace isolate. We
- 1:05:32Speaker 4: didn't start testing. We couldn't even test. South Korea was
- 1:05:36Speaker 4: testing ten thousand people in March. We were testing like
- 1:05:40Speaker 4: two hundred in a week in the United States. So
- 1:05:42Speaker 4: that's why the shutdowns occurred. I never was advocating in shutdowns.
- 1:05:46Speaker 4: I almost got I got lots of trouble for some
- 1:05:48Speaker 4: of the stuff I wrote at that time about shutdowns,
- 1:05:50Speaker 4: So I think that that's a mischaracterization of my position.
- 1:05:54Speaker 4: I understand why they occurred, but I'd never have advocated
- 1:05:57Speaker 4: for them, and I never thought the emergency was winding down.
- 1:05:59Speaker 4: In February twenty twenty, that was the first time I
- 1:06:01Speaker 4: was on on with you this is going to get bad,
- 1:06:04Speaker 4: this is going to infect a lot of people.
- 1:06:06Speaker 5: It wasn't going to wind down.
- 1:06:08Speaker 4: I think we could have if we would have been
- 1:06:10Speaker 4: very prompt and aggressive in January and February and half
- 1:06:13Speaker 4: of March and not wasted time with travel bands and
- 1:06:16Speaker 4: putting people on air force faces and saying the.
- 1:06:18Speaker 5: More we test, the worse we look.
- 1:06:20Speaker 4: In blocking private companies from developing tests, we would have
- 1:06:22Speaker 4: been we could have been Taiwan, but we weren't, and
- 1:06:26Speaker 4: one over one million Americans died because of that.
- 1:06:29Speaker 1: Yeah, you guys can check out the February twenty twenty
- 1:06:32Speaker 1: interview that we did. It's amazing how many of Amage's
- 1:06:37Speaker 1: predictions during that show came true, the negative ones, the
- 1:06:42Speaker 1: way he was too optimistic was on testing and stuff
- 1:06:45Speaker 1: like that, which they never did.
- 1:06:47Speaker 2: You know, we were all hoping that they'd come around
- 1:06:49Speaker 2: that they.
- 1:06:50Speaker 1: Actually execute on CDC protocols instead of what they actually did.
- 1:06:55Speaker 1: But no, I don't remember anything about emergency winding down.
- 1:06:59Speaker 1: I talk to Youma in January and in January personally,
- 1:07:03Speaker 1: and then February on the show, and.
- 1:07:06Speaker 2: At no point did he think this was gonna this
- 1:07:08Speaker 2: was going away.
- 1:07:12Speaker 1: Let's see, Michael says, how does Canada get away with
- 1:07:17Speaker 1: abolishing all forms of private for profit coverage entirely?
- 1:07:21Speaker 2: Even the UK doesn't do that.
- 1:07:24Speaker 5: So I think this is a kenda.
- 1:07:26Speaker 4: Is a complicated situation, and I have a lot of
- 1:07:28Speaker 4: familiarity with it because I'm friends with the healthcare executive there,
- 1:07:32Speaker 4: and I think, you know, so if you look at Canada,
- 1:07:35Speaker 4: as I said, doctors get paid about the same Canada
- 1:07:37Speaker 4: does liver transplants, bone marrow transplants. They're cutting edge doctors
- 1:07:41Speaker 4: that work in Canada. But what I think the problem,
- 1:07:44Speaker 4: so I think that they get away with it is
- 1:07:46Speaker 4: because they they ration the care and it just takes
- 1:07:49Speaker 4: a long time until you complain and then it actually happens.
- 1:07:52Speaker 4: So I don't you do definitely hear horror stories about
- 1:07:55Speaker 4: people that are in a queue for a very long time,
- 1:07:57Speaker 4: but I don't know that that's the norm. I think
- 1:07:59Speaker 4: most people they get frustrated with it, they deal with it,
- 1:08:01Speaker 4: but they they muddle their way the way through it.
- 1:08:04Speaker 4: And when there's true, true emergencies, what happens is people
- 1:08:06Speaker 4: that threaten to go to the US that I've got
- 1:08:08Speaker 4: an appointment in this hospital across Niagara Falls in the
- 1:08:11Speaker 4: US side, and then all of a sudden, things move
- 1:08:13Speaker 4: fast in the Canadian system once you start threatening that
- 1:08:15Speaker 4: you're going to go to the US. So they and
- 1:08:17Speaker 4: then there are there is q jumping. They don't all
- 1:08:20Speaker 4: sit in the same line. There is some kind of
- 1:08:24Speaker 4: triaging that's going on.
- 1:08:25Speaker 5: But it's not good.
- 1:08:27Speaker 4: And I think they if they didn't live so close
- 1:08:28Speaker 4: to the United States and have that ability, it may
- 1:08:31Speaker 4: they might feel it. But they clearly they you know,
- 1:08:34Speaker 4: they clearly have a problem. But it's more about things
- 1:08:40Speaker 4: that they don't consider emergency. So if you went there
- 1:08:42Speaker 4: with a broken ankle, you'll get it. It would get
- 1:08:44Speaker 4: taken care of, just like in the US. Or you
- 1:08:46Speaker 4: got on a liver transplant list, you get your liver
- 1:08:48Speaker 4: transplant and will probably be the exact same thing as
- 1:08:49Speaker 4: you would get in the United States. But it's that,
- 1:08:51Speaker 4: you know, my knee hurts, I need an MRI for
- 1:08:53Speaker 4: my knee, but I can walk and do things. Then
- 1:08:55Speaker 4: that's going to be stuck in the line. So I
- 1:08:57Speaker 4: think it's it's certain things that get put in that Q.
- 1:09:00Speaker 4: But they have they but they do. They don't have
- 1:09:04Speaker 4: any way around it. Everybody is they don't have any
- 1:09:07Speaker 4: kind of private option at all. But as I said,
- 1:09:09Speaker 4: many people, I think eighty five percent of the Candian
- 1:09:10Speaker 4: population lives within driving distance of the US order and
- 1:09:13Speaker 4: many of them have health insurance in the US or
- 1:09:15Speaker 4: they get a cash disc out.
- 1:09:16Speaker 5: Remember the US, if you pay cash, you can get
- 1:09:18Speaker 5: a really cheap you can get an MRI and everything
- 1:09:20Speaker 5: cheap if you bring money. So they do that too
- 1:09:22Speaker 5: as well.
- 1:09:24Speaker 1: Yeah, my wife once asked an MRI place if you
- 1:09:28Speaker 1: could pay cash, and they said, if you tell us
- 1:09:32Speaker 1: you don't have insurance, then the raid is three hundred dollars,
- 1:09:36Speaker 1: something ridiculous.
- 1:09:37Speaker 2: If you have insurance, the raid is double that. You know,
- 1:09:40Speaker 2: so it's absurd. But but yes, let's see.
- 1:09:50Speaker 1: Nacente asks are they do you know if they are
- 1:09:52Speaker 1: any organizations defending free choice in healthcare in Brazil.
- 1:09:58Speaker 3: No, I don't. I don't know really any organizations in Brazil.
- 1:10:04Speaker 1: So I know some organizations in Brazil, but none specifically
- 1:10:07Speaker 1: focused on healthcare.
- 1:10:08Speaker 5: So this is something that Malay will do in Argentina.
- 1:10:11Speaker 4: I don't know what his I've not seen any of
- 1:10:13Speaker 4: his health plans.
- 1:10:14Speaker 2: I haven't seen. That's a it's a really good question.
- 1:10:16Speaker 1: I mean, I think he he would like to. It
- 1:10:20Speaker 1: seems like that's something that he would need real legislation,
- 1:10:24Speaker 1: probably not top of his list to do. He needs
- 1:10:27Speaker 1: to get just the just the basic economy going, which
- 1:10:31Speaker 1: is going to be enough work. But you'd think that
- 1:10:33Speaker 1: he's a believer whether he could, whether he's whether he
- 1:10:37Speaker 1: is actually going to prioritize it or not, I don't know,
- 1:10:41Speaker 1: but that would be interesting.
- 1:10:44Speaker 2: And I don't know what system they have there.
- 1:10:46Speaker 1: I'm sure it's some form of socialized but I don't
- 1:10:48Speaker 1: know exactly how it works. Neo as damis, do you
- 1:10:53Speaker 1: know of Richard Hare and his work on IQ hairs
- 1:10:58Speaker 1: h A I E. R.
- 1:11:01Speaker 2: If so, what do you think of the research?
- 1:11:03Speaker 1: Also, do you know of any technology on the horizon
- 1:11:06Speaker 1: they could increase intelligence.
- 1:11:09Speaker 5: I don't know that name.
- 1:11:10Speaker 4: I don't I don't know of any technology that will
- 1:11:13Speaker 4: increase intelligence. I think maybe everybody will have AI assistance
- 1:11:16Speaker 4: that kind of increase our intelligence or our working knowledge,
- 1:11:19Speaker 4: but I don't know. I don't know any any specific
- 1:11:23Speaker 4: research to do that. There probably are some things that
- 1:11:26Speaker 4: happened in mice models that mice can go through mazes
- 1:11:28Speaker 4: faster if they, you know, do something, take some medicine,
- 1:11:31Speaker 4: But I don't know any of that off top.
- 1:11:33Speaker 2: Maybe new a link in the end.
- 1:11:35Speaker 1: But you're right, I mean AI agents are going to
- 1:11:37Speaker 1: increase intelligence, right, A computer increases on intelligence.
- 1:11:40Speaker 2: That's the these tools make us.
- 1:11:42Speaker 1: Much much smarter than we all h eneric, thank you. Okay,
- 1:11:48Speaker 1: buzz as a whole series of questions. Okay, why isn't
- 1:11:54Speaker 1: there a common cold vaccine?
- 1:11:56Speaker 4: Because the common cold is caused by like dozens and
- 1:11:59Speaker 4: dozens of differ viruses, and and those viruses mutate and change,
- 1:12:03Speaker 4: So it's not something that's really attractive or easy for
- 1:12:05Speaker 4: a pharmaceutical company to go after because it may not
- 1:12:08Speaker 4: even do that well. You know, people complain about the
- 1:12:11Speaker 4: COVID vaccines not blocking infections that would happen also with
- 1:12:14Speaker 4: the common cold vaccine. If you could against one of
- 1:12:17Speaker 4: about a dozen different viruses, that's why there's not not one.
- 1:12:23Speaker 2: Why is healthy chuns so complicated?
- 1:12:27Speaker 4: I think it's the what we talked about that that's
- 1:12:28Speaker 4: the whole entire system is set up with all of
- 1:12:31Speaker 4: these things trying to control costs and try to gain
- 1:12:34Speaker 4: access all these competing priorities, and it all evolved in
- 1:12:38Speaker 4: this mongrel mixed economy system with everybody just trying to
- 1:12:42Speaker 4: squeeze a little bit more of their survival out of it,
- 1:12:44Speaker 4: including insurance companies. And insurance companies are completely regulated by
- 1:12:49Speaker 4: slews and slews of regulation even before Obamacare. And that's
- 1:12:52Speaker 4: just what that's these kind of that DESI asking like,
- 1:12:54Speaker 4: you know, why is like the SEC regulation so complicated?
- 1:12:57Speaker 5: It's exact same phenomenon.
- 1:13:00Speaker 3: Another question that you get ask is why is health
- 1:13:03Speaker 3: insurance not insurance? Yeah, it's like, yes, it's complex, but
- 1:13:08Speaker 3: it's not even insurance.
- 1:13:11Speaker 4: A couple of days ago, there was an edit toiler
- 1:13:14Speaker 4: an article in the Wall Street Journal in the last
- 1:13:16Speaker 4: one or two days with that exact title of saying
- 1:13:18Speaker 4: that health insurance is not health insurance and.
- 1:13:21Speaker 1: It's it's all regulated. Every aspect of it is regulated.
- 1:13:24Speaker 1: It's it's unbelievable. And and indeed, states that regulate less
- 1:13:28Speaker 1: health insurance is a lot less complicated and a lot cheaper.
- 1:13:32Speaker 1: But you can't buy insurance cross state. It's one of
- 1:13:35Speaker 1: the one of the challenges.
- 1:13:36Speaker 4: And then there's all these all these pharmacy insurance companies,
- 1:13:39Speaker 4: highre pharmacy benefit managers, and then and there's all it's
- 1:13:42Speaker 4: just it's impossible to even keep up, keep up with
- 1:13:45Speaker 4: even if you're in the field.
- 1:13:47Speaker 2: All right, why don't we have a cure for cancer?
- 1:13:50Speaker 4: Cancer is not one thing I can't say. There's multiple
- 1:13:53Speaker 4: different types of cancer. Certain cancers are curable, certain ones
- 1:13:56Speaker 4: are not curable at this point. But I think so
- 1:13:59Speaker 4: it's people always think about cancers. It just like one
- 1:14:01Speaker 4: big thing, but it's not. There's so many different cancers.
- 1:14:04Speaker 4: Even within like lung cancer, there's ultiple different types of
- 1:14:06Speaker 4: lung cancer. We do have cancer preventative vaccines, like the
- 1:14:09Speaker 4: HPV vaccine that your own has talked about that prevents
- 1:14:12Speaker 4: cervical cancer, and that will probably get close to eradicating
- 1:14:18Speaker 4: most types of cervical cancer. We've got a vaccine against
- 1:14:20Speaker 4: hepatitis B, which reads liver cancer, and there are cancer,
- 1:14:23Speaker 4: certain leukemias, lynfilmas. We've got these great technologies called cart
- 1:14:26Speaker 4: therapies that are out there that are able to cure
- 1:14:29Speaker 4: many cancers that were not uncurable, and we've got great
- 1:14:32Speaker 4: immune with therapies. But you know, there's still some cancers
- 1:14:35Speaker 4: that have been very difficult for people to come up
- 1:14:37Speaker 4: with a solution or they get diagnosed too late, like
- 1:14:39Speaker 4: ovarian cancer, pancreatic cancer, certain brain tumors. But I think
- 1:14:43Speaker 4: we're getting there, and the technology is there, and it's
- 1:14:46Speaker 4: moving in the right direction in a way in a
- 1:14:48Speaker 4: pace that I probably haven't seen in the last twenty years.
- 1:14:51Speaker 1: Yeah, I mean the HPV data is stunning. I mean,
- 1:14:56Speaker 1: the idea that HPV is a cancer, is virus causing
- 1:14:59Speaker 1: cancer was pretty revolutionary, I think. I think that the
- 1:15:02Speaker 1: guy who came up with it was ridiculed for many
- 1:15:05Speaker 1: years before he managed to prove that it was there
- 1:15:07Speaker 1: was a cancer cause by a virus. And now that
- 1:15:12Speaker 1: they're doing vaccines, the number of cases is just plummeted.
- 1:15:16Speaker 2: It's uh and not surprisingly.
- 1:15:21Speaker 1: You know, the new Health and Human Services Secretary or
- 1:15:25Speaker 1: if K is anti the HPV vaccine.
- 1:15:28Speaker 4: Yeah, the more valuable, the more human beneficial of vaccine is,
- 1:15:31Speaker 4: the more he's going to attack it. Because I think
- 1:15:34Speaker 4: of him as a nilist, a destroyer. So he's just
- 1:15:36Speaker 4: not for health. He's anti health, is how I think
- 1:15:39Speaker 4: of him.
- 1:15:42Speaker 2: Let's see.
- 1:15:43Speaker 1: Boys wants to know if you have any thoughts on
- 1:15:45Speaker 1: fast thing, cold plunges, saundas, and living until one hundred
- 1:15:50Speaker 1: and fifty.
- 1:15:52Speaker 5: Just very general stuff.
- 1:15:53Speaker 4: I think that there's some there's some evidence that cold
- 1:15:55Speaker 4: plunges boost immunity. I don't know how much of boost longevity,
- 1:15:59Speaker 4: but you know, there's some studies that show that these
- 1:16:01Speaker 4: things are that fasting cold plunges may have some marginal benefit.
- 1:16:06Speaker 4: I don't know how much that actually accrues to over time.
- 1:16:08Speaker 5: I think there's a lot.
- 1:16:09Speaker 4: This is an area where there's a lot of research,
- 1:16:11Speaker 4: and you can probably find something that says the opposite
- 1:16:14Speaker 4: of that. But I don't think there's anything wrong with
- 1:16:16Speaker 4: cold plunging or fasting if you can tolerate it. It
- 1:16:19Speaker 4: seems to have at least some data and animal studies,
- 1:16:21Speaker 4: but I don't know that there's enough to say this
- 1:16:23Speaker 4: is what everybody.
- 1:16:24Speaker 5: Should be doing. But I don't really fault people for
- 1:16:26Speaker 5: doing or think it could be somewhat promising.
- 1:16:28Speaker 1: I don't know.
- 1:16:30Speaker 2: I just don't get it. Cold plunges is so painful.
- 1:16:35Speaker 2: I don't get it.
- 1:16:38Speaker 1: All, right, Jacob, Is it time? Is the time to
- 1:16:44Speaker 1: become a doctor? Variable by country? What about specialities? Does
- 1:16:49Speaker 1: one country do medical training best?
- 1:16:54Speaker 3: I don't.
- 1:16:54Speaker 5: I think it all depends on what.
- 1:16:55Speaker 4: If you really like medicine, it's always a good time
- 1:16:58Speaker 4: to be a doctor, I think if that's what's really
- 1:17:00Speaker 4: interested in, like the application of science to human problems
- 1:17:02Speaker 4: right there and then, and you get to see it
- 1:17:04Speaker 4: in front of your eyes. There's nothing else that does
- 1:17:06Speaker 4: that other than medicine, I think. And so I think
- 1:17:10Speaker 4: it all depends on what your personal values are and
- 1:17:12Speaker 4: what you find interesting. And that's same as specialties that
- 1:17:15Speaker 4: you know. Traditionally, medical students change their ideas for specialties
- 1:17:18Speaker 4: multiple times.
- 1:17:19Speaker 5: I didn't.
- 1:17:19Speaker 4: I was always infectious disease. I really like infectious disease.
- 1:17:23Speaker 4: But it all depends on what you like, what kind
- 1:17:26Speaker 4: of lifestyle you want to have where, what kind of science,
- 1:17:28Speaker 4: what kind of problems you want to solve? And I don't,
- 1:17:31Speaker 4: you know, I think that the training it depends I
- 1:17:33Speaker 4: think that in the United States you usually do four
- 1:17:36Speaker 4: years of college, four years of medical school and then residency,
- 1:17:39Speaker 4: and in Europe and you can't. In the UK, for example,
- 1:17:44Speaker 4: you just go directly into college and six years and
- 1:17:47Speaker 4: then into residency training. But in places like the UK,
- 1:17:52Speaker 4: because they have this socialized system, you can't just become
- 1:17:55Speaker 4: like an attending physician. You have to go you have
- 1:17:57Speaker 4: to have a spot in the I. So you go
- 1:17:59Speaker 4: through training be a junior doctor forever, not forever, but
- 1:18:02Speaker 4: for like six or seven years. So you come out
- 1:18:04Speaker 4: of that and you're a wizard compared to someone who
- 1:18:07Speaker 4: just in the United States you just do three years
- 1:18:09Speaker 4: of residency. And so if you look at someone that
- 1:18:12Speaker 4: so you know, I think that there's some pluses and minuses.
- 1:18:14Speaker 4: But they're in training forever and they learn a lot
- 1:18:16Speaker 4: of stuff, and they may be good at physical diagnosis
- 1:18:18Speaker 4: because they have less technology. But I think that they're
- 1:18:20Speaker 4: all very, very very similar to the US model. The
- 1:18:24Speaker 4: US and Canada are basically the same. Their training is identical.
- 1:18:28Speaker 4: It's just that you're a little bit younger in the
- 1:18:30Speaker 4: European places because you come out with six versus eight
- 1:18:33Speaker 4: years in the initial part of it. But anywhere you're
- 1:18:36Speaker 4: seeing lots of patients in like living in a hospital,
- 1:18:38Speaker 4: like a residency, you're coming out of that pretty pretty good,
- 1:18:42Speaker 4: pretty tired, but good.
- 1:18:45Speaker 2: Yeah.
- 1:18:45Speaker 1: Is it difficult for somebody who's trained in Europe or
- 1:18:50Speaker 1: somewhere overseas to practice medicine in the US.
- 1:18:53Speaker 4: Yes, it is only if the United States. It depends
- 1:18:57Speaker 4: on how much training you've had. If you just finished
- 1:18:59Speaker 4: medicals cool in you know, then then you can apply
- 1:19:03Speaker 4: for a residency. It's if you've done your residency training
- 1:19:05Speaker 4: in another country that they make you repeating. Only the
- 1:19:08Speaker 4: US and Canada are equivalent. They don't They don't make
- 1:19:10Speaker 4: any there's no disc either. You can if you do
- 1:19:12Speaker 4: your training in Canada that it doesn't matter. That's fine.
- 1:19:14Speaker 4: You can come to the US as if you were
- 1:19:15Speaker 4: trained to the US and vice versa. But any other
- 1:19:18Speaker 4: country you have to redo your residency training. There's some
- 1:19:21Speaker 4: there's there's some efforts to try and reform that and
- 1:19:24Speaker 4: find ways around that. That's happening because we have a
- 1:19:27Speaker 4: major shortage of doctors, especially primary care doctors. But in general, yes,
- 1:19:32Speaker 4: it's you're gonna have to repeat, you're gonna apply for
- 1:19:34Speaker 4: residency and repeat, so you can. You know, I remember
- 1:19:38Speaker 4: being in residency and there's people who are like neurosurgeons
- 1:19:40Speaker 4: and other countries that are redoing like a seven year
- 1:19:42Speaker 4: neurosurgery residency because they want to work in the United States.
- 1:19:44Speaker 4: So a lot of that is is a little bit
- 1:19:46Speaker 4: it's all bureaucratic, and it's also it's it's it's the
- 1:19:49Speaker 4: doctors in the United States that create those problems. They're
- 1:19:51Speaker 4: the ones who make those regulations because they don't want
- 1:19:53Speaker 4: the competition. So there is this guild mentality where we've
- 1:19:55Speaker 4: got to keep people from other countries. We've got to
- 1:19:57Speaker 4: make it hard for them so they don't come here
- 1:19:59Speaker 4: and compete with us and drive down our salaries.
- 1:20:02Speaker 3: Yeah, whereas if you're an NHS doctor, you can move
- 1:20:05Speaker 3: to Australia, New Zealand, South Africa.
- 1:20:12Speaker 1: So within within the British what do you call a
- 1:20:14Speaker 1: crown system or whatever, the Commonwealth?
- 1:20:17Speaker 2: Within the Commonwealth, what.
- 1:20:19Speaker 1: About doctors who uh experienced doctors doctors twenty twenty is
- 1:20:24Speaker 1: in the field. Can they move to the US and
- 1:20:26Speaker 1: pick up the practice.
- 1:20:28Speaker 4: So they can there's there's a one trick you can do,
- 1:20:31Speaker 4: so they would to be a fully licensed independent doctor,
- 1:20:33Speaker 4: they'd have to do redo a residency. Really, but a
- 1:20:36Speaker 4: big academic medical center can sponsor, they can say we
- 1:20:39Speaker 4: are in the state, will give the state will say
- 1:20:42Speaker 4: you have a restricted license.
- 1:20:44Speaker 5: You can be a doctor, but only at this hospital.
- 1:20:47Speaker 4: So so then so then you can end up becoming
- 1:20:49Speaker 4: like an indentured servant to that hospital, because that's your
- 1:20:51Speaker 4: whole livelihood is tied to that. You can't move anywhere
- 1:20:54Speaker 4: else because you don't want to do this residency. So
- 1:20:56Speaker 4: that's one trick is that like a very highly skilled
- 1:20:58Speaker 4: transplant surgeon might come of Pittsburgh and they'll have a
- 1:21:01Speaker 4: restricted license where they can only work at University of
- 1:21:03Speaker 4: Pittsburgh for example.
- 1:21:04Speaker 3: Wow, is it possible to do like one year of
- 1:21:07Speaker 3: fellowship if you've done residency somewhere else and then I
- 1:21:11Speaker 3: can let you stay or.
- 1:21:13Speaker 4: Most states require three years of postgraduate training to get
- 1:21:17Speaker 4: an unrestricted license.
- 1:21:18Speaker 5: You've got to do at least three years.
- 1:21:20Speaker 1: Yeah, I think my dad worked. My dad was a
- 1:21:22Speaker 1: doctor worked in the US. Bet it was always because
- 1:21:26Speaker 1: he was sponsored by a major medical center. So he
- 1:21:29Speaker 1: worked at you know, Mass General for a couple of years.
- 1:21:31Speaker 1: He worked at in h in Seattle. Bet it was
- 1:21:34Speaker 1: always on a very short contract and sponsored by one entity.
- 1:21:41Speaker 1: I don't think it was an unrestricted license. Let's see thoughts.
- 1:21:47Speaker 1: This is for now the final question. What are your
- 1:21:51Speaker 1: thoughts on medical tourism.
- 1:21:53Speaker 5: I think it's a.
- 1:21:54Speaker 4: Good thing, but you have to be it's buyer beware
- 1:21:57Speaker 4: because we've seen some horrible things happen for examp in
- 1:22:00Speaker 4: Mexico where there wasn't sterilization and people got really horrible
- 1:22:03Speaker 4: fungal infections that were there. So medical tourism is in
- 1:22:07Speaker 4: general good, but I think you really need to make
- 1:22:09Speaker 4: sure that you're going to a place that has appropriate sterilization,
- 1:22:12Speaker 4: infection control procedures. You've got to make sure that you've
- 1:22:15Speaker 4: got your follow up arranged because some doctors may don't
- 1:22:17Speaker 4: want to touch touch you because you were taken care
- 1:22:20Speaker 4: of by another doctor somewhere else.
- 1:22:21Speaker 5: So make sure you.
- 1:22:22Speaker 4: I would just look and see what you're getting into,
- 1:22:24Speaker 4: and look at the reviews, talk to people who have
- 1:22:26Speaker 4: done it, meet the doctors. This isn't something you should
- 1:22:29Speaker 4: do lightly. And what you know as an infectious disease doctor.
- 1:22:32Speaker 4: One of the biggest risks is not someone like dying
- 1:22:34Speaker 4: on an operating table. It's the post operative infections because
- 1:22:37Speaker 4: many places have drug resistant bacteria, they may not have
- 1:22:40Speaker 4: proper sterilization or infection control in the hospital, so someone
- 1:22:43Speaker 4: might go there to get you know, breast implants and
- 1:22:44Speaker 4: come back with a horrible, totally drug resistant infection that
- 1:22:47Speaker 4: causes sepsis because they got infected with something at the
- 1:22:50Speaker 4: at the operative site. So just be be really careful
- 1:22:53Speaker 4: about what you do and make sure you read the
- 1:22:55Speaker 4: reviews and talk to people before.
- 1:22:57Speaker 1: You do it. Yeah. Wait, why don't you tell us
- 1:23:00Speaker 1: again how people can get involved and how they can
- 1:23:03Speaker 1: get in touch with you guys, and you know, if
- 1:23:06Speaker 1: you've got anything coming up, anything exciting coming up?
- 1:23:11Speaker 3: Yeah, So in the show description, there's a link to
- 1:23:16Speaker 3: our website. It's ww dot a f CM dot org
- 1:23:20Speaker 3: and you can contact me under people. My email is
- 1:23:23Speaker 3: our sc HU. You are at a f CM dot org.
- 1:23:29Speaker 3: And yeah, we're working on different things. We had a
- 1:23:33Speaker 3: conference in Austin a year and a half ago. We're
- 1:23:38Speaker 3: working to maybe having another conference this year, but that's
- 1:23:40Speaker 3: not finally yet. And yeah, we're gonna start writing articles
- 1:23:46Speaker 3: and be more more active in the public domain.
- 1:23:51Speaker 2: Are they see you've got some recommended talks?
- 1:23:54Speaker 1: Where can people find like talks on healthcaret people are
- 1:23:58Speaker 1: interested generally in the field of healthcare. We can they
- 1:24:00Speaker 1: find talks from objectivists on the topic.
- 1:24:04Speaker 3: Our website is full of them. But I would highly
- 1:24:07Speaker 3: recommend the talks we had a year and a half
- 1:24:09Speaker 3: ago by Amish, by Don Watkins, by Greg Selmery. It's
- 1:24:18Speaker 3: under events on our website.
- 1:24:21Speaker 2: Okay, so it's all on the website.
- 1:24:23Speaker 5: We even a healthcare is not a right? That talk
- 1:24:25Speaker 5: is up there too.
- 1:24:25Speaker 1: Oh, that's right, Lanta peakoffs healthcare is not a right?
- 1:24:28Speaker 1: Uh is Also that wasn't an afgham event, but in
- 1:24:32Speaker 1: the in the nineties, and you're on.
- 1:24:34Speaker 3: We have three of your lectures there as well.
- 1:24:37Speaker 2: Yeah, I think I did. I did some some some events.
- 1:24:41Speaker 2: Uh those were fun.
- 1:24:42Speaker 3: And also John John Lewis that's right, that's right. So
- 1:24:47Speaker 3: we have great material. It's we've rebooted the old website,
- 1:24:51Speaker 3: so please take a look and yeah, get in touch.
- 1:24:54Speaker 2: Great.
- 1:24:55Speaker 1: I am super excited that afgham is is kind of
- 1:24:59Speaker 1: back in gay aged and rebooted and looking forward to
- 1:25:04Speaker 1: the work that you're going to be doing.
- 1:25:05Speaker 3: Ray.
- 1:25:06Speaker 1: Always always a pleasure a miss to have you on.
- 1:25:10Speaker 1: We should talk sometimes.
- 1:25:11Speaker 2: I don't know. Is it worth talking about bood flu?
- 1:25:15Speaker 5: Well, it's always worth talking about birth.
- 1:25:16Speaker 2: Okay, so let's let's I'll have you back on to
- 1:25:19Speaker 2: talk about bood flu. I think that that would be
- 1:25:21Speaker 2: that would be fun. It's always good to talk about
- 1:25:25Speaker 2: bood flu. Doesn't sound good? Yes, we'll have to do
- 1:25:29Speaker 2: that and uh yeah, all the best guys for.
- 1:25:34Speaker 1: For twenty twenty five at Afghan and I'll see you
- 1:25:36Speaker 1: both in Florida in uh in ten days.
- 1:25:40Speaker 2: Thanks for having us, all right, good night everybody.
- 1:25:42Speaker 1: I will see you guys, not tomorrow because I'm in
- 1:25:46Speaker 1: New York tomorrow, but i'll see you from New York
- 1:25:48Speaker 1: on Wednesday.
- 1:25:51Speaker 2: Well, we will talk then bye everybody. I'm going for
- 1:25:55Speaker 2: a cold plunge in New York